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Abstract 
Lactobacilli are Gram-positive bacteria used in fermented foods. Many species are 
commensal microbiota members that confer host benefits. This thesis investigated 
lactobacilli mitigation of organophosphate and neonicotinoid pesticide toxicity in mammals 
and insects, respectively. Lactobacillus rhamnosus GG (LGG) and GR-1 (LGR-1) were 
found to sequester, but not metabolize, organophosphate pesticides (parathion and 
chlorpyrifos) in solution. For LGG, this sequestration reduced organophosphate pesticide 
absorption in a Caco-2 intestinal Transwell model and promoted survival of Drosophila 
melanogaster lethally exposed to chlorpyrifos. Supplementation of mice with LGR-1 was 
found to alter host xenobiotic metabolism in the liver, and consequently chlorpyrifos 
metabolism following acute exposure. Drosophila supplemented with L. plantarum, a species 
indigenous to the fly, elicited an immune response that was correlated with increased survival 
following imidacloprid (neonicotinoid) exposure. Taken together, these experiments suggest 
that humans and honeybees could benefit from simple and affordable dietary 
supplementation with Lactobacillus strains to offset pesticide exposure. 
Keywords 
Probiotics, Lactobacillus, bioremediation, environmental toxicology, pesticide, 
organophosphate, neonicotinoid, colony collapse disorder, honeybee, IMD/Relish   
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Chapter 1  
1 General Introduction 
This chapter is reproduced/adapted with permission (Appendix A and Appendix B) from: 
Trinder M, Bisanz JE, Burton JP, Reid G. 2015. Probiotic lactobacilli: a potential 
prophylactic treatment for reducing pesticide absorption in humans and wildlife. Benef 
Microbes 6(6):841-7. 
Trinder M, Bisanz JE, Burton JP, Reid G. 2015. Bacteria need “sleep” too?: microbiome 
circadian rhythmicity, metabolic disease, and beyond. University of Toronto Medical 
Journal. 92(3):52-5. 
1.1 Pesticides  
Pesticides are heavily used in agriculture to protect crops from damage associated with 
insects, weeds, plant pathogens, and other microbial infestations. Despite their intended 
purpose of killing, incapacitating, or repelling organisms deemed pests, pesticides 
frequently have negative consequences on human and wildlife health. Pesticide pollution 
is still a major consequence of agricultural practices. However, since many pesticide 
classes have been designed to be less toxic to vertebrates, prevailing dogma has 
suggested that at low concentrations these chemicals should have negligible effect on 
vertebrate species.  But, this appears not to be the case. Recent studies in bees (1), birds 
(2), fish (3), and humans (4) suggest that chronic low dose pesticide exposure can cause 
long-lasting negative consequences on health, especially neural function. Therefore, 
humans need to develop improved methods to protect both the environment and 
themselves from pesticide exposure.  
These toxic compounds frequently enter the gastrointestinal tract following oral ingestion 
of contaminated food or water (5). Gastrointestinal-xenobiotic interactions are 
complicated by the presence of bacterial communities, collectively known as the 
microbiota. The gastrointestinal microbiota plays an important role in metabolizing 
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xenobiotics (6), influencing host xenobiotic metabolism (7), and preventing systemic 
toxin absorption (8). It is well-established that bacteria can break down pesticides in 
contaminated soil and water in a process known as bioremediation (9, 10). However, to 
our knowledge, little work has been carried out to test whether food-grade bacteria can 
act to reduce the systemic absorption of pesticides in vivo.  
1.1.1 Organophosphate pesticides 
Due to their toxicity to humans, the physiological effects of first generation 
organophosphate pesticides are best characterized. There is a wide range of 
organophosphate pesticides that all possess phosphate ester functional groups (Figure 1-
1). Organophosphate pesticides are applied as insecticidal sprays for agriculture and 
landscaping. These inhibit acetylcholinesterase, an enzyme responsible for metabolizing 
the neurotransmitter acetylcholine (Figure 1-2). Organophosphate pesticides include: 
parathion, malathion, methyl parathion, chlorpyrifos, diazinon, dichlorvos, phosmet, 
fenitrothion, tetrachlorvinphos, azamethiphos, and azinphos methyl. Due to the poor 
selectivity of these compounds, many countries have restricted or even banned their 
usage due to their off-target toxicity (5). However, since they are effective at eliminating 
pests and are affordable, organophosphate pesticides are still used by many businesses, 
especially in developing countries (11, 12). Current treatment for acute organophosphate 
poisoning includes pralidoxime and atropine, which bind organophosphates and are 
muscarinic acetylcholine receptor antagonists, respectively. But these nonspecific 
treatments do not negate concerns of chronic low dose organophosphate pesticide 
exposure being implicated in neurodevelopmental disorders (13),  diabetes (14), cancer 
(15), heart disease (16) and several other chronic diseases. Further research into the long-
term safety of these compounds is needed with respect to susceptibility to secondary 
chronic diseases.  Notably, the World Health Organization is encouraging greater 
national regulation of pesticides on a global level, with emphasis on developing 
countries, in hopes to reduce pesticide use and associated morbidities and mortalities.  
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Figure 1-1. Chemical structure of organophosphate pesticides. 
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Figure 1-2. Organophosphate pesticide toxicity. 
(A) The currently accepted health risks for pesticide toxicity in humans are neurotoxicity, 
skin irritation, carcinogenesis, and endocrine system disruption. (B) The mechanism of 
action of organophosphate pesticides is to inhibit acetylcholinesterase (AChE), leading to 
an exacerbation of acetylcholine (ACh)-acetylcholine receptor (AChR) signaling in nerve 
and muscle cells. Images were modified from Servier Medical Art by Servier under the 
Creative Commons Attribution 3.0 Unported License 
(http://www.servier.com/Powerpoint-image-bank). 
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1.1.2 Neonicotinoid pesticides 
Neonicotinoid pesticides are classified as neurotoxins (insecticides) that act as an insect-
selective nicotinic acetylcholine receptor agonist (17). The use of neonicotinoid 
pesticides in agriculture has become widespread with almost all US corn and about 1/3 of 
US soybean crops being planted with neonicotinoid-treated seeds. As of 2008, 
neonicotinoids made up 80% of seed treatment sales for agricultural crops, but they can 
also be used with water to irrigate plants. Neonicotinoid pesticides in order of popular 
usage include: imidacloprid, thiamethoxam, clothianidin, acetamiprid, thiacloprid, 
dinotefuran, and nitenpyram. Imidacloprid has particularly received attention for its link 
to undesired toxicity to bees and “colony collapse disorder” (18).  Bees experience 
growth abnormalities (1, 18), motor deficiencies (19, 20),  neurologic abnormalities (21), 
and/or death (19) following imidacloprid exposure. Bees act as critical pollinators for 
roughly 35% of the global food crop (22). The fact that neonicotinoids also adversely 
affect insectivorous avian species (2), suggests evidence of bioaccumulation. So far, the 
literature suggests acute mammalian neonicotinoid pesticide toxicity is remarkably rare 
and almost negligible at environmentally-relevant levels (23).  Thus, the dilemma facing 
the agriculture industry is how to resolve the issue of preventing bee decline, while at the 
same time mitigating crop losses associated with pest infestations.  
1.2 Bioremediation of pesticides 
1.2.1 Bioremediation of organophosphate pesticides 
The presence of microorganisms has a direct impact on the stability of organophosphate 
pesticides in soil (24, 25) and aquatic ecosystems. This suggests that these compounds 
can act as important carbon, nitrogen, and/or phosphorus sources for microorganisms. 
Furthermore, there is growing evidence of bacterial strains that encode and demonstrate 
organophosphate pesticide metabolism. However, identification of individual isolates 
capable of degrading both parent pesticide and potentially toxic metabolites is rare (26, 
27). This has given rise to  the potential use of multi-organismal mixtures or genetically-
engineered  strains capable of completely degrading organophosphate pesticide-
contaminated environments.  Currently two major families of microbial hydrolases have 
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been shown to confer organophosphate pesticide metabolism: opd phosphotriesterases 
and mpd metallo-ß-lactamases (26).  
The best classified and most ubiquitous pesticide-metabolizing gene, opd, was originally 
discovered on plasmids harbored by Sphingobium fuliginis ATCC 27551 (28) and 
Brevundimonas diminuta GM (29, 30) isolated from organophosphate-treated soils. 
Enzymes encoded by opd display broad temperature and pH enzymatic kinetics and are 
able to metabolize numerous different organophosphate pesticide structures (26).  
Interestingly, the opd gene from S. fuliginis and B. diminuta are flanked by an insertion 
operon associated with a transposase and resolvase (31), which  contains contain multiple 
tra genes to promote conjugation (32), and has an integrase to promote chromosomal 
incorporation (33). This supports the finding of the opd gene and associated homologues 
spreading to other strains of soil bacteria by lateral gene transfer (34). However, it is still 
debated whether the opd gene originated in response to environmental organophosphate 
exposure or as a coincidental off target effect. An alternative hypothesis states that the 
opd genes and related homologues encode hydrolytic phosphotriesterases that function 
primarily in phosphate metabolism (35). It is interesting to speculate on what the 
potential expansion of microorganisms with opd-like genetic potential could be telling us 
about human interactions with the environment.  
The other major gene family associated with organophosphate pesticide metabolism is 
the methyl parathion degradation (mpd) gene family. Mpd genes do not display any 
notable (>20%) homology to opd or other genes involved in organophosphate pesticide 
degradation (36).  The mpd genes impart an uncommon ability to degrade methyl 
parathion, methyl paroxon, and chlorpyrifos (26). Although the mpd genes are primarily 
chromosomally encoded, numerous soil bacteria have been both shown and predicted to 
contain mpd genes based on conserved metallo-ß-lactamase domains (36). These findings 
provide evidence for non-organophosphate specific degradative function of mpd proteins.  
1.2.2 Bioremediation of neonicotinoid pesticides 
Studies of environmental bioremediation of pesticides has recently expanded beyond the 
class of organophosphate pesticides. Genera of soil bacteria, such as Pseudoxanthomonas 
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(37), Ochrobactrum (38), Mycobacterium (39), Stenotrophomonas (40),  Ensifer (41), 
and Bacillus (42) have been shown to have imidacloprid-degrading potential. However, 
unlike bacterial-mediated organophosphate metabolism, the mechanisms of bacterial 
neonicotinoid degradation still remain largely unclear.  
1.3 Introduction to the human microbiota 
Humans contain an ‘organ’ composed of 2-6 pounds of bacteria, primarily residing in the 
gastrointestinal tract, which has gone largely unappreciated until recently. The 
gastrointestinal microbiome is a dynamic ‘organ’ that performs important physiological 
functions for its host, and can also be a factor in disease. The human body is initially 
colonized during vaginal birth by microorganisms from the mother’s genital tract and 
stool. Subsequent colonization and dynamic changes result due to the newborn’s 
exposure to breast milk and environmental microbes (43-46). The diverse bacterial 
communities of young children typically mature to resemble the distinct and stable 
profiles of an adult by 1-2 years of age (45, 46). Microbes abundantly colonize the human 
gastrointestinal tract. By adulthood, this region contains 1- to 10-fold more bacteria 
(approximately 1000 species) than the total human cell count (depending on host body 
mass) (47) and encodes 100-fold more gene functions (48). Thus, it is not surprising that 
these bacterial communities, known as  microbiotas, play important roles in shaping their 
host’s physiology. However, until the recent decreased costs and increased throughput of 
nucleotide sequencing, comprehensive investigations of the gastrointestinal microbiota 
were not possible. Today, the interest and tools to explore the human microbiome 
(microbiota and gene functions) have become sufficient to investigate many of the 
fundamental questions regarding the importance of these host-microbe interactions to 
human health. The systems biology nature of host-microbiota interactions make questions 
in these fields of study particularly challenging to answer in humans. However, animal 
models may provide valuable insights into these processes for the time being. The ability 
to colonize germ-free animals such as fruit flies, zebrafish, or rodents with whole or 
selective human microbiota samples is an important study option. 
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1.3.1 The microbiota and xenobiotics 
Xenobiotic metabolism refers to the biochemical processes that convert compounds 
foreign to an organism, such as drugs and toxins, into alternative forms. Typically, these 
processes are performed by specialized enzymes that convert lipophilic compounds into 
more hydrophilic products to enable excretion. In mammals, the predominant organ 
system involved in xenobiotic metabolism is the smooth endoplasmic reticulum of the 
liver. The smooth endoplasmic reticulum of epithelial cells present in the gastrointestinal 
tract, lungs, kidneys, and skin have small roles in localized xenobiotic metabolism. For 
most orally consumed drugs and toxins, first pass metabolism is an important 
consideration for evaluating the amount of parent xenobiotic that reaches systemic 
circulation (Figure 1-3). Since oral drugs must be absorbed in the intestine and pass 
through the liver via portal circulation prior to reaching systemic circulation, often the 
amount of parent xenobiotic consumed is much greater than what reaches systemic 
circulation. Thus, portal circulation is an elegantly designed system that attempts to 
mitigate the xenobiotic distribution throughout the body. Xenobiotic metabolism can be 
defined as having two distinct phases: phase I and phase II. It is important to note that 
xenobiotic metabolism can occur in any order, not all xenobiotics have multi-phase 
metabolism, and some metabolites are more toxic than the parent compound. 
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Figure 1-3: First pass metabolism.  
Orally consumed drugs and toxins must be absorbed by gastrointestinal enterocytes 
before traveling to the liver via portal circulation. The liver often metabolizes these 
compounds such that the amount of unchanged xenobiotic that reaches systemic 
circulation is reduced relative to the initial dose. Images were modified from Servier 
Medical Art by Servier under the Creative Commons Attribution 3.0 Unported License 
(http://www.servier.com/Powerpoint-image-bank). 
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Phase I metabolism of xenobiotics includes oxidation, reduction, and/or hydrolysis 
reactions that are typically performed by the heme-containing cytochrome P450 (CYP) 
superfamily. Oxidized CYP isoforms bind xenobiotics and perform biotransformation by 
coupling CYP reduction to oxygen production, through interactions between 
nicotinamide adenine dinucleotide phosphate (NADPH) and cytochrome P450 
oxidoreductase (POR). The human CYP superfamily contains 57 genes (e.g. CYP3A4) 
divided into 18 families (e.g. CYP3) and numerous subfamilies (e.g. CYP3A) based on 
amino acid sequence identity ≥ 40% or ≥ 55%, respectively (49). However, the CYP 
isoforms most relevant to human drug metabolism include CYP3A4, CYP2D6, 
CYCP2C8/9, and CYP1A2 (Figure 1-4). The ability of many CYP450 isozymes to be 
induced or inhibited by environmental factors make them of clinical significance to 
pharmacotherapy and toxicology. Other enzymes involved in phase I metabolism include: 
flavin-containing monooxygenases, alcohol dehydrogenase, aldehyde dehydrogenase, 
peroxidases, and monoamine oxidase. The remarkable number and complex regulation of 
phase I metabolic processes demonstrate the importance of these biological processes to 
organismal homeostasis.  
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Figure 1-4: Percentage of commonly used drugs metabolized by a given cytochrome 
P450 isoform (2012). 
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Phase II metabolism of xenobiotics are conjugation reactions. Often phase I metabolism 
does not generate compounds polar enough for renal elimination. Phase II metabolism 
adds endogenous polar substrates such as glucuronic acid, methyl groups, sulfate or 
sulfuryl groups, glutathione, and/or acetyl groups to a parent or metabolic derivative 
xenobiotic. Phase II metabolism typically requires phase I metabolism first, since reactive 
sites (hydroxyl-, carboxyl-, amino, or sulfhydryl) on a xenobiotic are required for 
conjugation to occur.  
The field of pharmacogenomics has demonstrated the importance of dosing many 
common medications on a personalized basis. This strategy is based on observations that 
differences in human genotype can have major implications to therapeutic toxicity or 
efficacy. The implications of how relatively small genetic variations can have a crucial 
impact on drug dosing are intriguing. An emerging area of research that likely has 
underappreciated implications to pharmacology and toxicology is the microbiota, or 
microbial communities (largely bacteria) that reside most profoundly in the 
gastrointestinal tract (50). This field has been termed “pharmacomicrobiomics” (50). The 
microbiota has been shown to interact with drugs (51-53) and alter host xenobiotic 
metabolism (7, 54, 55). These interactions are clinically relevant based on observations of 
the microbiota conferring protection or toxicity to xenobiotic exposure depending on the 
nature of the interaction. Studies in germ-free mice have demonstrated that the 
microbiota is critical for mitigating the absorption and bioaccumulation of cadmium and 
lead (56). Alternatively, chemical inhibition of the intestinal Escherichia coli ß-
glucuronidases have been shown to relieve the rate-limiting toxicity of the anticancer 
drug, camptothecin (57). These studies suggest that microbiome-drug interactions can be 
targeted, which adds an additional layer of complexity to pharmacology. Given that the 
gastrointestinal microbiota displays much larger interpatient variation than genetics, the 
role that the microbiota may play in personalized medicine, at least for orally 
administered drugs, requires further investigation. A database of the currently known 
drug-microbiome interactions can be found at http://pharmacomicrobiomics.com. Further 
study is particularly important since the mechanisms of these interactions remain largely 
unexplored. Currently it has been shown that the typical lipoteichoic acid receptor, Toll-
like receptor 2, is necessary for Cyp1a1 induction (58) and that bacterial metabolites can 
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modulate the pregnane X receptor, which coordinates detoxification gene upregulation in 
response to many xenobiotics (59). Thus, it is possible that immunomodulation and/or 
distant site small molecule signaling are plausible explanations for microbiota regulation 
of host xenobiotic metabolism. Since organophosphate and neonicotinoid pesticides are 
substrates for CYP-mediated metabolism by the mammalian liver, the relevance of 
applying pharmacomicrobiomics principles for the application of limiting pesticide 
toxicity holds merit. 
Given the association of microbiota community profiles with an expanding list of 
pathologies, it is important to understand how xenobiotics shape the composition. Once 
mature, the microbiota was believed to be relatively stable in terms of composition (60). 
However, studies with diet (61), circadian rhythm (62, 63), and, not surprisingly, 
antibiotics (64) suggests more dynamic status.  
Certain microbiota patterns from dietary consumption of artificial sweeteners (65), 
emulsifiers (66), high fat (67), and red meat (68-70) appear to be affiliated with disease 
progression. Environmental toxins including pesticides (71) and heavy metals (72) can 
alter these patterns. This emphasizes that microbes are more sensitive to external factors 
than originally anticipated.  
Current microbiota analyses frequently only take a ‘who is there approach’ in their 
experimental design. Most studies utilize 16S rRNA gene sequencing to identify a 
fingerprint of bacterial community composition. The use of other –omics approaches 
such as metagenomics, metatranscriptomics, and metabolomics/proteomics better assess 
microbial communities in terms of ‘what is the potential?’, ‘what are they doing?’, and 
‘how are they doing it?’, respectively. Notably, just because microbiota abundance 
profiles do not change does not mean their behaviour is unaltered.  
In conclusion, a multi-tool approach is preferable to truly understand systems biology 
problems associated with the complex interactions between microbial communities and 
their hosts. 
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1.3.2 Drosophila melanogaster as a simplified model of host-
microbiota interactions 
1.3.2.1 Overview 
One of the biggest assumptions in microbiome research is that both the abundance and 
identity of microorganisms as a whole have the potential to directly influence host 
physiology in different ways (73). This is different to the reductionist concept that a 
single pathogen is responsible for a disease, as proven by Koch’s postulates. In order to 
test the microbiome concept, germ-free mice are often used and implanted with microbial 
communities to assess disease causation. Due to the cost and infrastructure challenges of 
maintaining germ free colonies, an alternative approach is needed to investigate host-
bacterial interactions, and by extension to investigate mechanisms of probiotic efficacy in 
a living system. An ideal approach would include the ability to easily extract material for 
high throughput screening in an affordable model in combination with a bacterial 
organism that quickly reproduces, and in which microbial manipulation can be easily 
performed.  Drosophila melanogaster is an excellent candidate as it possesses all of these 
qualities. The tools to investigate host-microbe relationships in Drosophila are continuing 
to evolve, but the species has been extensively used for understanding human stem cell 
biology, neurobiology, genetics, and innate immunity. It has been hypothesized that 75% 
of human disease-associated genes have functional homologs in Drosophila (74). 
Drosophila melanogaster, commonly known as the fruit fly, has been used to study 
bacterial pathogenesis innate immunity. Thus, the idea of using Drosophila for 
developing an understanding of the role that symbiotic bacteria play in the regulation of 
host physiology has recently been suggested (75-77). The efficient and convenient germ-
free Drosophila model has yet to be used in probiotic studies. Axenic Drosophila 
colonies can be derived and maintained relatively easily without the requirement of 
expensive animal facilities. In contrast to the aforementioned complexity of the human 
microbiota, the Drosophila gut microbiota has a low microbial diversity (1-30 species) 
and is typically dominated by Lactobacillus and Acetobacter (78-80).  This makes it 
simpler to decipher what each species is doing. Most importantly, Drosophila 
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experimentation is affordable, convenient, timely, and does not require approval by 
animal ethics review boards. These characteristics make Drosophila the most ideal high-
throughput in vivo model for understanding general mechanisms of host-microbiota 
interactions.  
1.3.2.2 Drosophila gut anatomy 
In comparison to the human gastrointestinal tract, the Drosophila gut has several major 
differences, but overall structure and function are remarkably similar. The adult gut of 
Drosophila melanogaster is composed of a tubular structure composed of an epithelial 
monolayer encircled by visceral muscles, nerves, and tracheae (81). In contrast to 
humans, gut transit time in adult Drosophila is considerably faster, and has been shown 
to proceed in less than 1 h (82, 83). The adult gut of Drosophila is sequentially divided 
into the foregut, midgut, and hindgut. Unlike the critical role of mucous in the 
mammalian intestine, the adult Drosophila midgut is encircled by a luminal layer of 
peritrophic matrix (lattice of chitin fibrils and chitin binding proteins) that shields the 
epithelium from the bacteria-dominant microbiota, which contains approximately 3.5 x 
105 colony forming units (75). The foregut and hindgut are encircled by a luminal layer 
of impermeable cuticle (82). This division of luminal compartments is important for 
segregation of midgut digestive enzymes into either the endoperitrophic or 
ectoperitrophic space (84). The pH of the adult midgut varies with diet but is 
approximately 7, <4, 7-9, and 5 in the anterior midgut, copper-cell region (midgut region 
R3), posterior midgut, and hindgut, respectively (82, 85). Acidic conditions of the 
copper-cell region are analogous to the mammalian stomach and similarly function to 
denature proteins, enable certain peptidase enzymatic activity, promote metal and lipid 
absorption, and kill microorganisms (82, 86). Thus, the relatively well-conserved 
anatomy and signaling pathways that control intestinal development, regeneration, and 
pathology make Drosophila a useful simplified model that permits a reductionist 
approach to microbiome research and many other fields (87).  
The Drosophila gut physiology is regulated by enteric neurons and endocrine signaling. 
The neuronal innervation of the Drosophila gut utilizes a variety of neurotransmitters 
such as serotonin and insulin (82). In contrast to the mammalian intestine that contains 
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enteric innervation throughout its entirety, the Drosophila gut is only innervated at the 
esophagus-crop-anterior midgut junction, midgut-hindgut junction, and posterior hindgut 
(88). These innervation locations are predominately associated with muscle valves, which 
suggests an important role for peristaltic regulation. In addition, some nerve fibers 
innervate the epithelium (82). Further gut regulation results from secretions from 
endocrine glands, neuroendocrine organs, and gut resident enteroendocrine cells. 
Enteroendocrine cells are most prevalent in the midgut and are responsible for multiple 
peptides relevant to modulating intestinal physiology (82). Taken together, the diverse 
neuronal and hormonal inputs to the Drosophila gut make it a convenient model for the 
mammalian intestine.  
The adult midgut is the best characterized gut region and is the primary site of digestion 
and absorption of nutrients (Figure 1-5). Epithelial cells of the midgut contain enterocytes 
or enteroendocrine cells, which are derived from intestinal stem cells. These intestinal 
stem cells are also found in the foregut and hindgut.  The midgut is subdivided into 6 
anatomical regions (R0 to R5) based on metabolic and digestive function (82). 
Drosophila contain numerous carbohydrases, proteases, lipases, lysozymes, chitinases, 
and glucanases. These enzymes degrade macromolecules and microbial cell wall 
components, which suggest nutrients may also be derived from the bacteria and yeast 
present on the fly diet of rotting fruit (82). The importance of the microbiota to fruit flies 
are also supported by studies with germ-free or antibiotic-exposed flies where bacteria 
are critical regulators of Drosophila growth (77), mating (89), and immune regulation 
(90). Taken together, these observations emphasize the intimate and critical relationship 
between Drosophila and indigenous and environmental microorganisms.   
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Figure 1-5. 3D model of the Drosophila melanogaster midgut.  
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It is important to note that Drosophila feeding behavior and intestinal morphology 
change throughout development. Drosophila larvae utilize mouth hooks to continuously 
eat solid food in order to sustain rapid growth and development required for 
metamorphosis (82). In contrast, adult Drosophila feed less and ingest food/liquid 
through their proboscis. Furthermore, unlike adult flies, larval guts contain 4 gastric ceca 
in the anterior gut for digestion and nutrient absorption. At each stage of development—
larvae, pupae, and adult—Drosophila have distinct gastrointestinal tissues (82). The 
larval and pupal midguts degenerate and are discarded by adult flies following eclosion 
(82),  
1.3.2.3 Drosophila melanogaster microbe sensing  
Drosophila microbe-sensing immune responses to pathogen-associated molecular 
patterns (PAMPs) can largely be separated into two district pathways. Pioneering work in 
Drosophila observed rapid activity in either the Toll or immune deficiency (IMD) 
pathway in response to septic injury. The Toll pathway is activated by lysine (Lys)-type 
peptidoglycan (Gram-positive bacteria) and β-1,3 glucan (fungi). Alternatively, the IMD 
pathway is activated by diaminopimelic acid (DAP)-type (Gram-negative and Gram-
positive bacilli bacteria) (91). Together the Toll and IMD pathways are critical for 
upregulating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) 
response genes such as antimicrobial peptides drosomycin and diptericin, respectively. 
Traditional studies of Drosophila systemic immunity have demonstrated that the 
normally aseptic fat body (analogous to the mammalian liver) is the predominate organ 
involved in Toll and IMD signaling in response to sepsis. However, the complexity of 
Drosophila mucosal immunity still remains perplexing given the direct contact between 
host tissue and microorganisms. 
Unlike the Toll pathway, the IMD pathway plays a critical role in the Drosophila gut for 
mitigating pathogens and modulating the microbiota (92-95, Figure 1-6). The gut IMD 
pathway is initiated in response to DAP-type peptidoglycan sensing by the peptidoglycan 
recognition protein family (PGRP) proteins: membrane-bound PGRP-LC and 
intracellular PGRP-LE. IMD pathway stimulation results in downstream activation of the 
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transcription factor, Relish, which initiates transcriptional activation of genes encoding 
antimicrobial peptides and other effector molecules. Flies deficient in IMD pathway 
activation are significantly more susceptible to pathogenesis by Gram-negative organisms 
such as Serratia marcescens (96) and Pseudomonas entomophila (97). Alternatively, the 
dominant symbiotic genera of the Drosophila microbiota, Lactobacillus and Acetobacter, 
contain DAP-type peptidoglycan that initiates a constitutive basal stimulation of the IMD 
pathway (90, 98). This is unexpected given that constitutive IMD-dependent immune 
activation would likely have negative consequences to host physiology. Thus, given that 
Drosophila lack adaptive immune systems, these conflicting observations suggest a 
remarkably complex regulation of optimal IMD signaling in response to beneficial and 
pathogenic microbes in the Drosophila gut. In addition, these observations suggest there 
are underexplored host physiological benefits of IMD-dependent intestinal activation by 
the symbiotic microbiota (75). 
The Drosophila IMD/ NF-κB pathway is complex and contains several negative 
regulators at different hierarchical levels. PGRP-SC and -LB degrade peptidoglycan in an 
attempt to prevent overstimulation of the IMD pathway in the gut (99, 100). In addition, 
Pirk (aka PIMS, Rudra) is a negative feedback loop regulator which is also activated by 
Relish in response to IMD signaling. Pirk antagonizes the IMD pathway ligand-receptor 
interaction of DAP-peptidoglycan with PGRP-LC (101-104). Interestingly, despite 
microbiota dependent activation of Relish, upregulation of downstream antimicrobial 
genes diptericin  and  Cecropin A1 (CecA1) is antagonized in a gut-specific manner by 
Caudal (105). The multiple layers of IMD pathway regulation highlight the essential 
nature of modulating host-microbe interactions for host physiological homeostasis.  
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Figure 1-6. IMD pathway regulation in the Drosophila melanogaster midgut. 
Images were modified from Servier Medical Art by Servier under the Creative Commons 
Attribution 3.0 Unported License (http://www.servier.com/Powerpoint-image-bank). 
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Fundamental questions not addressed regarding gut IMD pathway regulation are: 1) How 
does constitutive Relish activation by the indigenous microbiota shape host physiology?; 
2) Is this pathway targetable? The Relish pathway has been shown to have important 
roles other than antimicrobial peptide regulation. Notably, Relish promotes host survival 
in response to noxious stimuli such as radiation (106), and regulates cell death (107). 
Thus, Drosophila may be an excellent model for deciphering the physiological 
consequences of host-microbiota-immune interactions induced in response to common 
probiotic Lactobacillus species used by humans.  Furthermore, honeybees are known to 
contain functional homologues of the Relish protein. Given that honey bee colony 
collapse disorder has been attributed to a combination of toxic immunosuppressive 
pesticides (108) and pathogens, it is interesting to speculate on the potential of using 
beneficial microbes to augment honeybee survival through a Relish-like pathway. 
1.4 Lactobacillus and in vivo bioremediation 
1.4.1 Probiotic potential 
The importance of the microbiota for numerous aspects of host physiology and health, 
suggests that its modulation with probiotics, prebiotics, synbiotics (probiotic and 
prebiotic combination), and/or antibiotics hold therapeutic promise (109). Probiotics have 
been defined by the Food and Agriculture Organization of the United Nations and the 
World Health Organization as “live microorganisms which when administered in 
adequate amounts confer a health benefit on the host” (110). Alternatively, prebiotics are 
non-digestible food supplements that benefit host physiology by selectively stimulating 
the growth and/or function of a limited number of beneficial bacteria (111). Fermented 
foods, which frequently contain Lactobacillus and/or Bifidobacterium, are the best 
documented for associations with health and safety (112). However, several studies are 
now utilizing nucleotide sequencing technology to identify candidate probiotics based on 
organisms present in healthy controls, but absent in diseased counterparts (113).  
Lactobacilli are Gram-positive commensal bacteria.  Lactobacillus is a genus used to 
ferment a number of foods. It is a common constituent of the oral cavity, urogenital tract, 
and gastrointestinal tract of humans and a wide variety of animals. This has made 
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Lactobacillus a key genus of probiotic organisms (114), with some general and specific 
strain effects described.  
Probiotics have been shown to temporarily alter the function and metabolic read-out of 
the gastrointestinal microbiota (115) and mucosal immune function (116). This is 
particularly interesting given that exposure to chlorpyrifos (organophosphate pesticide) 
can induce dysbiosis of the gut microbiota in rodent and in vitro models (71, 117, 118). 
Thus, there is potential for probiotic effects to help retain homeostasis. This is important 
since the “healthy” gastrointestinal microbiota plays a role in protecting the human from 
xenobiotic insults (58, 119). However, this emerging theory needs to be empirically 
investigated and validated in vivo for each toxin and probiotic strain. It is reasonable to 
suggest that probiotic lactobacilli may be a useful therapeutic against pesticide-induced 
gut dysbiosis (71, 117, 118) or even pesticide uptake without dysbiosis, and result in 
reduced pesticide absorption via direct degradation or passive binding and/or modulation 
of host xenobiotic metabolism. 
1.4.2 Lactobacilli-mediated protection of gastrointestinal integrity  
The tight junctions of the intestinal epithelium form an important barrier against microbes 
and toxic substances. Rats chronically exposed to organophosphate pesticide 
demonstrated increased intestinal permeability and both perturbed expression and 
localization of tight junctions (120). It is possible that perturbed gut barrier function can 
lead to increased paracellular absorption of toxic compounds through a feed-forward 
mechanism, and thus exacerbate systemic pesticide exposure. Furthermore, chronic 
impairment of gut barrier function is hypothesized to contribute to  “leaky gut syndrome” 
(121). Studies are currently investigating the contribution of leaky gut syndrome to the 
pathogenesis of both intestinal and systemic diseases such as: celiac disease, 
inflammatory bowel disease, type 1 diabetes, autism, and numerous others. The 
association of pesticide exposure and diabetes in developed countries raises questions 
regarding the long-term safety of many pesticide compounds (122). It is interesting to 
speculate on how chronic low-dose pesticide exposure may influence the development 
and/or progression of various other diseases.  
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Numerous studies suggest that lactobacilli have the ability to enhance gut barrier function 
and thus potentially reduce absorption and secondary damage caused by pesticides. For 
instance, Lactobacillus plantarum MB452 was found to enhance the expression of the 
tight junction proteins occludin, zona occluden-1 and -2, and cingulin in the Caco-2 
intestinal cell-line (121). Strains of lactobacilli have also been shown to maintain gut 
barrier function when the epithelium has been challenged by bacterial pathogens (123, 
124) and excessive unconjugated bilirubin (125). Rats treated with the pesticide, 
malathion, suffered hepatotoxicity due to excessive inflammation (124). Hence, the 
finding that probiotic Lactobacillus casei DN-114 001 (126) and Lactobacillus 
rhamnosus GG (127) were able to dampen the pro-inflammatory response in a BALB/c 
mouse model of dextran sodium sulfate-induced colitis, could be relevant to the 
preventing inflammatory reactions associated with pesticide exposure. Similarly, 
Lactobacillus casei DN-114 001 appears to prevent excessive inflammation by 
downregulating activity of the NF-κB pathway in the intestinal epithelium and increasing 
the population of regulatory T-cells in the mesenteric lymph nodes (128). Future studies 
should investigate if these mechanisms of lactobacilli-dependent reduction of 
inflammation and immune regulation can be applied to pesticides.  
1.4.3 Antioxidative potential of lactobacilli 
Chronic exposure to organophosphate, neonicotinoids, and glufosinate ammonium 
pesticides has been associated with increased oxidative stress and associated genotoxicity 
in humans (11, 12). The use of antioxidant therapies has some effectiveness against 
organophosphate-induced toxicity in rat models (129). This suggests they either reduce 
the generation of pesticide-induced reactive oxygen species or enhance host antioxidant 
enzymatic capacity. There are numerous studies demonstrating that lactobacilli can 
ameliorate oxidative stress both in vitro and in vivo. For instance, Lactobacillus casei 
ATCC 334 was able to decrease gastrointestinal DNA damage of rats exposed to the 
carcinogen 1,2-dimethylhydrazine (130).  Lactobacillus rhamnosus has also been shown 
to prevent aflatoxin B1-induced DNA damage and absorption in a Caco-2 Transwell 
model (131). Thus, lactobacilli appear to be protective against a wide range of toxin-
induced oxidative stress and downstream cellular damage, and their use as a probiotic 
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might succeed through antioxidant activity.  
1.4.4 Interactions with organophosphate pesticides 
Several species of Lactobacillus have been shown to remove organophosphate pesticides 
from dairy products (123, 124), kimchi (132), and wheat. Indirect evidence suggests that 
lactobacilli are able to metabolize organophosphate pesticides via phosphatase enzymes 
(133, 134). One study concluded that the organophosphate pesticide degrading ability of 
Lactobacillus brevis WCP902 was associated with functional expression of the 
organophosphate hydrolase (OpdB) gene (134-136). These findings are not surprising; as 
classical bioremediation has identified strains of bacteria with enhanced ability to 
degrade pesticide compounds. Genetic engineering approaches have improved the ability 
of Escherichia coli to detoxify organophosphate pesticides by displaying the 
organophosphate hydrolase enzyme at the cell surface (123, 124). The organophosphate 
hydrolase gene is a phosphotriesterase (aryldialkylphosphatase) that has been well 
characterized for organophosphate metabolism and is found in several species of 
Lactobacillus.  
1.5 Rationale and hypotheses  
1.5.1 Lactobacillus mitigation of organophosphate absorption and 
toxicity   
Despite the support for lactobacilli having the potential to degrade organophosphate 
pesticides in vitro (123, 124, 126, 132), research is needed to validate if these findings 
can be transferable to reducing systemic absorption of pesticides in vivo. Recently, it was 
demonstrated that consumption of yogurt-supplemented with Lactobacillus rhamnosus 
GR-1 was able to reduce systemic bioaccumulation of mercury and arsenic in Tanzanian 
pregnant women (8). These studies provide proof-of-concept for the idea of in vivo 
“bioremediation”.  Thus, although the chemical structures of heavy metals and pesticides 
differ drastically, proof-of-principle exists for the consumption of locally produced 
nutritious yogurt to prevent the absorption of heavy metals and perhaps other 
environmental toxins such as pesticides in heavily contaminated regions of the 
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developing world. We hypothesize that the ability of lactobacilli to degrade and/or bind 
certain pesticides, enhance gut barrier function, modulate host xenobiotic metabolism, 
and influence gastrointestinal microbiota community structure will reduce the negative 
consequences of pesticide absorption though the gastrointestinal tract (Figure 1-7). 
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Figure 1-7. Proposed mechanisms of lactobacilli-mediated reduction of both 
gastrointestinal pesticide absorption and systemic toxicity. 
Certain strains of probiotic lactobacilli can reduce pesticide toxicity directly by either (A) 
sequestering pesticides from the gastrointestinal environment or (B) metabolizing 
pesticides into less toxic metabolites (123, 124, 132). (C) Lactobacilli could also reduce 
the gastrointestinal cytotoxicity caused by pesticide-induced reactive oxygen species 
(ROS) generation (130, 131).  (D) By enhancing tight junction expression, lactobacilli 
could reduce paracellular absorption of pesticides (131). (E) Direct interactions between 
lactobacilli and gastrointestinal tract can modulate both the activity and expression of 
enterocyte and liver (not shown) xenobiotic metabolizing enzymes relevant to host 
pesticide metabolism (54, 55, 58, 131). (F) Lactobacilli could modulate both the activity 
and composition of gastrointestinal microbiota (115), which are known to influence 
numerous components of host physiology and the microbiome that are relevant to 
reducing pesticide absorption. Images were modified from Servier Medical Art by 
Servier under the Creative Commons Attribution 3.0 Unported License 
(http://www.servier.com/Powerpoint-image-bank). 
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1.5.2 Protective effect of Lactobacillus against imidacloprid toxicity 
in a Drosophila melanogaster model of colony collapse 
disorder 
Lactobacilli are commensal bacteria that colonize honeybees (133, 134) and confer 
beneficial effects to honeybee health and colony size (134-136). Lactobacilli have also 
been shown to be important stimulators of insect immunity (78, 137, 138). Alternatively, 
the neonicotinoid, imidacloprid, has been shown to suppress invertebrate immune 
function and consequently increase these organisms susceptibility to viral infection (139). 
Thus, the indirect damage of neonicotinoid pesticides to bee health may be more of a 
problematic issue than anticipated.  We hypothesize that probiotic lactobacilli would 
mitigate pathogen susceptibility and general physiological consequences of imidacloprid-
toxicity through immune stimulation in a Drosophila melanogaster model of “colony 
collapse disorder”.  
Drosophila melanogaster (the common fruit fly) is a convenient insect organism to 
model the potential for lactobacilli to mitigate pesticide-induced toxicity in bees (139). 
Both fruit flies and honeybees have a core microbiota composed of Lactobacillus, with 
Lactobacillus plantarum being a major species in both hosts (78-80). But more 
importantly, both species are insects, and are therefore profoundly affected by 
imidacloprid. We plan to use this pilot study to demonstrate proof-of-principle for 
mitigating imidacloprid toxicity in an insect model before experimenting in at risk 
honeybee populations.   
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Chapter 2   
 
2 Reduction of organophosphate pesticide absorption 
and toxicity by probiotic Lactobacillus rhamnosus 
The material in this chapter is currently under review at Applied and Environmental 
Microbiology as a full length article and has a content license that can be found in 
Appendix D. 
Trinder M, McDowell TW, Ali SN, Leong HS, Sumarah MW, Reid G. 2016. Reduced 
organophosphate pesticide absorption and downstream toxicity by probiotic 
Lactobacillus rhamnosus. Appl Environ Microbiol [under revision, manuscript ID: 
AEM01510-16]. 
2.1 Abstract 
Organophosphate pesticides, commonly used in agriculture, can pose health risks to 
humans and wildlife. We hypothesized that dietary supplementation with Lactobacillus, a 
genus of commensal bacteria, could prevent absorption and toxicity of consumed 
organophosphate pesticides (parathion and chlorpyrifos). Several Lactobacillus species 
were screened for the ability to tolerate 100 ppm of chlorpyrifos (CP) or parathion in 
MRS broth using 24 h growth curves. Lactobacilli strains were identified that were 
unable to reach stationary phase culture maxima and displayed abnormal culture 
morphology in response to pesticide. Further characterization of commonly used, 
pesticide-tolerant and pesticide-susceptible, probiotic L. rhamnosus GG (LGG) and L. 
rhamnosus GR-1 (LGR-1) revealed that both strains could significantly sequester 
organophosphate pesticides from solution after 24 h co-incubations. This effect was 
independent of metabolic activity, as no difference in organophosphate sequestration was 
observed between live and heat-killed strains. Furthermore, LGR-1, and more notably 
LGG, reduced the absorption of 100 µM parathion or CP in a Caco-2 Transwell model of 
the small intestinal epithelium. To determine the effect of sequestration on acute toxicity, 
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newly adult Drosophila melanogaster were exposed to food containing 10 µM CP with 
or without supplementation by live LGG. Drosophila supplemented with LGG 
simultaneously, but not 3 d prophylactically, mitigated CP-induced mortality. In 
summary, the results suggest that L. rhamnosus may be useful for reducing toxic 
organophosphate pesticide exposure by passive binding. These findings could be 
transferable to clinical and livestock applications due to the affordable, practical, and 
convenient ability to supplement products with food grade bacteria. 
2.2 Introduction 
Organophosphate pesticides are a class of insecticide under scrutiny for being linked to 
toxic effects in both humans and wildlife (1). However, these compounds are still 
commonly used in agriculture and pest control programs. Organophosphate pesticides 
include parathion, malathion, methyl parathion, chlorpyrifos (CP), diazinon, dichlorvos, 
phosmet, fenitrothion, tetrachlorvinphos, azamethiphos, and azinphos-methyl. 
Organophosphate pesticides irreversibly inhibit acetylcholinesterase to induce excessive 
cholinergic stimulation (2, 3). The potential off-target health consequences of 
organophosphate pesticide exposure to humans include: neonatal developmental 
abnormalities (4, 5), endocrine disruption (6), neurodegeneration, cancer (7, 8), metabolic 
disruption (9), heart disease (10), chronic kidney disease, and other less common 
pathologies. In addition, organophosphate pesticides are reported to have negative 
impacts on honey bee colonies, which are critical pollinators for numerous agricultural 
products (11-13).  Although the evidence is mixed and often correlative, the original use 
of these organophosphates as nerve agents strongly suggests that these pesticides are not 
aligned with human or wildlife health. 
Despite negative consequences, the affordability and need to prevent crop losses 
associated with insect infestations suggest that organophosphate pesticide use will 
continue in the near future. One long-considered counter to these effects is the use of 
microbes to detoxify organophosphate pesticide-contaminated environments (14-20). 
Classical bioremediation efforts have identified numerous strains of soil bacteria that 
contain genetically diverse phosphotriesterases capable of organophosphate degradation 
(15). Moreover, the symbiotic relationship between Burkholderia strains and the bean 
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bug, Riportus pedestris, have been shown to confer resistance of these insects to 
insecticides (21). Taken together, these observations suggest that microorganisms could 
be employed to reduce the toxic effects of organophosphate insecticides in vivo. 
There has been development within bioremediation research to investigate the potential 
of transitory food-grade bacteria to prophylactically prevent the absorption of 
environmental toxins such as pesticides (22), heavy metals (23), and aflatoxin (24, 25). 
Many lactobacilli are commonly used in fermented foods such as yogurt, cheese, 
sauerkraut, pickles, beer, wine, cider, kimchi, cocoa, and kefir (26). Lactobacilli have 
also been shown to be a natural and beneficial member of numerous organisms relevant 
to humans such as livestock, honeybees (27), and fish (28). Notably, lactobacilli have 
been shown to reduce organophosphate pesticide contamination of dairy products (29, 
30). The mechanism of action used by lactobacilli against organophosphate pesticides 
remains unclear and is commonly attributed to phosphatase capabilities. However, one 
kimchi isolate, Lactobacillus brevis WCP902, was shown to contain the opdB gene that 
conferred the active ability to degrade CP (31).  Similarly, the common probiotic, 
Lactobacillus rhamnosus GG (LGG), has a predicted hydrolase/phosphotriesterase 
(LGG_RS02045) with high sequence similarity to the experimentally-validated parathion 
hydrolase (opd) found in Brevundimonas diminuta (20).  
The aim of this study was to better characterize the in vivo bioremediation potential of 
probiotic food-grade bacteria interacting with organophosphate pesticides. We 
hypothesized that the direct binding or metabolism of organophosphate pesticides by L. 
rhamnosus strains would reduce toxin absorption and downstream organismal toxicity.  
2.3 Materials and Methods 
2.3.1 Chemicals 
CP (catalog number: 45395) and parathion (catalog number: 45607) were obtained from 
Sigma-Aldrich. Stock solutions were prepared at 100 mg/mL dimethyl sulfoxide (Sigma-
Aldrich) and stored frozen at 4°C until usage.  
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2.3.2 Bacterial strains and culture 
Lactobacilli strains used were: L. rhamnosus GG, L. rhamnosus GR-1, L. casei ATCC 
393, L. delbrueckii DSM 20074, L. plantarum ATCC 14917, L. crispatus ATCC 33820, 
L. fermentum ATCC 11739, L johnsonii DSM 20053, L. reuteri ATCC 2773, L. 
rhamnosus ATCC 7469.  Lactobacilli were inoculated from Difco lactobacilli de Man, 
Rogosa and Sharpe (MRS) agar (BD, catalog number: 288130) plates into MRS broth. 
Inoculated MRS broth cultures were subcultured and incubated overnight (18 h) at 37°C 
anaerobically and statically for experimental procedures. Bacteria were heat-killed by 
incubation at 56°C for 90 min when necessary. Bacterial killing was confirmed by spread 
plating 100 µL of bacterial culture on MRS agar plates and verifying the absence of 
colony growth following 3 d of anaerobic incubation. 
2.3.3 Pesticide tolerance assay 
Overnight broth cultures (stationary phase) were subcultured (1:100 dilution) into 96 well 
plates (Falcon, catalog number: 351177) containing MRS broth with or without the 
addition of pesticide or vehicle (DMSO).  Plates were incubated at 37°C and read every 
30 min for 24 h at a wavelength of 600 nm using a Labsystems Multiskan Ascent 
microplate reader.  
2.3.4 RNA extraction, reverse transcription, and qPCR 
Overnight subcultures of LGG were pelleted at 5000 g (15 min), washed and resuspended 
in 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 6.8). LGG 
was exposed to 100 ppm of CP or parathion or vehicle. LGG-pesticide solutions were 
incubated protected from light at 37°C with gentle shaking. At 1 and 3 h, 500 µL of 
culture was mixed with 1 mL of RNAprotect Bacteria Reagent (Qiagen, catalog number: 
76506) for 10 min, then pelleted by centrifugation at 5000 g for 5 min. Supernatants were 
discarded. Pellets were flash frozen with liquid nitrogen and stored at -80°C until RNA 
extraction. 
For RNA extraction, pellets were resuspended in 1 mL TE buffer containing 20 mg/mL 
lysozyme (Sigma-Aldrich, catalog number: L6876) and 50 U/mL mutanolysin (Sigma-
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Aldrich, catalog number: M9901). Samples were incubated at 37°C for 30 min before 
being pelleted by centrifugation at 5000 g for 5 min at 4°C. Supernatants were discarded 
and pellets were dissolved in 1 mL of TRIzol (Ambion, catalog number: 15596018) by 
repeated pipetting. After phase separation with chloroform according to the 
manufacturer’s protocol, the aqueous phase was combined with equal volume of 100% 
ethanol. RNA purification was continued using a PureLink RNA Mini Kit (Ambion, 
catalog number: 12183025) with on-column treatment of PureLink DNase treatment 
(Ambion, catalog number: 12185010). RNA quantity and purity was accessed with a 
NanoDrop ND-1000 spectrophotometer (Thermo Scientific).  RNA was stored at -80°C 
until reverse transcription. 
 
cDNA was prepared from 200-2000 ng of purified total RNA using a High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, catalog number: 4368813). qPCR 
was performed with a 7900HT Sequence Detection System (Applied Biosystems) in 20 
µL reactions using Power SYBR Green Master Mix (Applied Biosystems, catalog 
number: 4368702) with 200 µM of appropriate forward and reverse primers. Primers used 
for qPCR analysis are listed in Supplementary Table 2-1. qPCR results were analyzed 
using SDS RQ 6.3 manager software (Applied Biosystems) and relative gene expression 
was calculated using the 2−ΔΔct method.  
2.3.5 Pesticide binding and metabolism assay 
Overnight bacterial cultures were pelleted at 5000 g, washed and resuspended in 50 mM 
HEPES (pH 6.8). Bacterial-buffer or buffer-alone solutions were incubated with 
parathion or CP protected from light at 37°C for 24 h with gentle shaking. Cultures were 
pelleted and supernatant collected. Pellets were washed in 50 mM HEPES, resuspended 
in methanol, and sonicated for 15 min. Supernatants were again collected for pellet 
assessment of organophosphate levels.  
Pesticide levels were determined by high performance-liquid chromatography (HPLC) 
using a Poroshell 120 column (100 × 4.6 mm, 2.7µm; Agilent, Mississauga, Ontario) and 
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an ultraviolet light detector based on a modified protocol (32). CP and parathion were 
detected at 288 and 275 nm wavelengths, respectively. Solvent flow rate was 1 mL/min 
of A (H2O + 0.1% trifluoroacetic acid) and B (acetonitrile + 0.1% trifluoroacetic acid). 
Solvent gradient was set to 25, 25, 100, 100, 25, and 25 percent B at 0, 2, 9, 11, 11.5, and 
13 min, respectively. Sample peak area units were compared to a linear relationship of 
appropriate standards of known concentrations.  
2.3.6 Caco-2 cell culture and Transwell experimentation 
Caco-2 cells were obtained as a gift from Dr. Brad Urquhart (Western University, 
London, Canada). Caco-2 cells were routinely maintained at 37°C in atmospheric 
conditions with 5% CO2. Cells were cultured in Dulbecco's Modified Eagle Medium 
(Gibco, catalog number: 11960044) supplemented with 10% heat-inactivated fetal bovine 
serum (Gibco), 1 mM sodium pyruvate (Gibco, catalog number: 11360070), 1% MEM 
non-essential amino acids (Gibco, catalog number: 11140050), 4 mM L-glutamine 
(Gibco, catalog number: 25030081), and 100 U/mL penicillin-streptomycin (Gibco, 
catalog number: 15140122). Cells were used experimentally between passages 35-45.  
Cells were seeded onto 12mm Transwell (12-well with 0.4 µm pore polyester membrane 
insert, Corning, catalog number: 3460) plates at a concentration of 1.5 x 105 cells/insert. 
Cells were differentiated by culturing cells for 21 d as described (33). Prior to absorption 
experimentation, apical and basolateral compartments were washed 3x and resuspended 
with Hank’s balanced salt solution (Gibco, catalog number: 14025092). Cells were 
treated apically with 100 µM of parathion or CP in the presence or absence of 5 x108 
colony forming units of LGG or LGR-1. Basolateral sampling (100 µL) with replacement 
was performed at 30 min, 1 h, and 2 h. Following absorption experimentation, Caco-2 
monolayer integrity was confirmed by lucifer yellow (lucifer yellow CH lithium salt, 
Biotium, catalog number: 80015) rejection according to manufacturer’s instructions.  
2.3.7 Drosophila husbandry 
Wild type Canton-S (stock number: 1) stocks were obtained from Bloomington 
Drosophila Stock Center at Indiana University. Drosophila were maintained using media 
containing 1.5% agar (w/v), 1.73% yeast (w/v), 7.3% cornmeal (w/v), 7.6% corn syrup 
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(v/v), and 0.58% acid mix (v/v) at 22°C with 12 h light/dark cycles. For experimental 
procedures, media were supplemented with or without pesticide prior to solidification. 
Experiments with adult Drosophila used newly eclosed flies. All experiments were 
performed in polypropylene Drosophila vials (GEN32-121 and GEN49-102, Diamed Lab 
Supplies Inc., Mississauga, ON, Canada) containing 10 mL of feed with 15-25 flies/tube. 
2.3.8 Adult Drosophila survival assays 
Fifteen to twenty-five newlhy eclosed Drosophila were transferred into standard vials 
containing media supplemented with vehicle or CP and monitored daily for survival. 
Media was supplemented with 100 µL (109 CFU) of washed and concentrated LGG or 
phosphate-buffered saline vehicle when experimentally appropriate and allowed to air dry 
before use. 
2.3.9 Drosophila negative geotaxis assay 
Negative geotaxis assays were performed as previously described (34). Mean distance 
climbed (after 3 s) of 5 replicates from 3 independent experiments were determined. 
2.3.10 Drosophila microbiota analysis 
Whole Drosophila were surface sterilized with 70% ethanol, homogenized with a 
handheld motorized pestle in 0.01 M phosphate-buffered saline.  Serially diluted fly 
homogenates were spot plated onto MRS agar plates. Plates were incubated anaerobically 
at 37°C and enumerated after 48 h incubation. 
2.3.11 Statistical analyses 
All statistical analyses were performed in GraphPad Prism 6 using one-way analysis of 
variance tests with Tukey’s multiple comparisons tests or Kuskal-Wallis test with Dunn’s 
multiple comparison tests. Alternatively, Mantel-Cox and Gehan-Breslow-Wilcoxon tests 
were used for Drosophila survival analyses. 
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2.4 Results 
2.4.1 Lactobacilli vary in their ability to tolerate high levels of 
organophosphate pesticides 
In an effort to determine a strain of Lactobacillus able to tolerate high levels of 
organophosphate pesticides, lactobacilli were screened for the potential to tolerate 100 
ppm of parathion or CP using growth curves. In general, lactobacilli growth was largely 
unaltered by the presence of parathion or CP relative to the vehicle control. Based on the 
solubility maxima of parathion and CP at 37°C, pesticide concentrations greater than 100 
ppm were not evaluated.  However, L. rhamnosus GR-1, L. casei ATCC 393, and L. 
delbrueckii DSM 20074 demonstrated significantly reduced growth (p < 0.05) in the 
presence of parathion or CP (Figure 2-1A). Organophosphate pesticide treatment 
significantly reduced the stationary phase growth maxima of these lactobacilli compared 
to vehicle control treatment (Figure 2-1B). The organophosphate-induced growth 
deficiency was associated with abnormal shiny and mucoid culture morphologies for L. 
casei ATCC 393 and L. delbrueckii DSM 20074 (Figure 2-1C). It is hypothesized that 
these strains were more susceptible to organophosphate pesticide-induced insult due to 
more permeable cell walls or fewer enzymes capable of detoxifying their environment, 
and thus, consequently formed biofilm-like structures. These biofilm-like phenotypes 
were not observed in other lactobacilli strains exposed to organophosphate pesticides.  
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Figure 2-1. Lactobacilli vary in their ability to tolerate high levels of 
organophosphate pesticides. 
(A) Percent maximal growth was calculated from 24 h growth curve of optical density 
600 nm using the area under the growth curve of pesticide-treated bacteria relative to 
vehicle treatment of each bacterial strain. (B) Representative growth curves of 
Lactobacillus casei ATCC 393 and Lactobacillus delbrueckii DSM 20074. (C) 
Representative image of lactobacilli cultures following 24 h treatment with 100 ppm 
parathion or CP or vehicle. Red box outlines bacteria with differential culture 
morphology following organophosphate pesticide treatment compared to vehicle. Data 
are depicted as means ± SEM of 3 independent experiments with triplicate technical 
replicates. CP = chlorpyrifos, LGG = Lactobacillus rhamnosus GG, LGR-1 = 
Lactobacillus rhamnosus GR-1. 
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2.4.2 Organophosphate hydrolase gene, LGG_RS02045, in L. 
rhamnosus GG was not induced by organophosphate 
pesticide exposure 
The National Center for Biotechnology Information’s BLASTP tool identified 
WP_014569076.1 (corresponding gene LGG_RS02045 or php) as sharing high sequence 
similarity to the experimentally confirmed parathion hydrolase present in Brevundimonas 
diminuta (20). Protein modelling with Protein Homology/analogY Recognition Engine V 
2.0 software best-matched WP_014569076.1 as a likely member of the metallo-
dependent hydrolases and phosphotriesterase-like protein superfamily and family, 
respectively, with 100% confidence and 52% identiy. To test for substrate-induced gene 
expression, relative php expression was determined in nutrient exhausted stationary phase 
LGG cultures that contained parathion or CP as the sole carbon and nitrogen source (in 
50 mM HEPES buffer). However, no induction of php by 100 ppm of parathion or CP 
was observed at either 1- or 3 h post-exposure (Figure 2-2). These findings contradict the 
predicted role of php in hydrolysis of organophosphate pesticides.   
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Figure 2-2. Organophosphate hydrolase gene, LGG_RS02045, in Lactobacillus 
rhamnosus GG is not induced by organophosphate pesticide exposure. 
Relative gene expression of php was determined from stationary phase LGG cultures (109 
CFU/mL) following 1 and 3 h exposures to 100 ppm of parathion or CP or vehicle in 50 
mM HEPES buffer. Data are expressed as means ± SEM of 3 independent experiments 
with triplicate technical replicates.  
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2.4.3 L. rhamnosus GG and GR-1 can bind, but not metabolize, 
organophosphate pesticides 
The commonly used commercial probiotics, LGG and LGR-1, were characterized for 
organophosphate pesticide binding or metabolism since they displayed opposite 
phenotypes of unimpaired and impaired growth in organophosphate-containing media, 
respectively. Both LGG and LGR-1 significantly sequestered parathion and CP from 
solution (p < 0.05); however, this effect was much more pronounced with CP (Figure 2-
3A). Given the similar molecular structures of parathion and CP, the enhanced binding of 
CP by LGG and LGR-1 is likely a result of the 3 chlorine atoms on the benzene ring of 
CP, opposed to the nitrate group on the benzene ring of parathion. Alternatively, the 
greater hydrophobicity of CP, compared to parathion, could explain greater sequestration 
mediated by hydrophobic interactions. Interestingly, organophosphate sequestration was 
observed by LGG and LGR-1 even after heat-killing and the extent of binding was 
similar to live bacteria (Figure 2-3A). This finding further supports that the predicted 
organophosphate hydrolase gene, php, from LGG is not involved in organophosphate 
pesticide metabolism. The binding of organophosphate pesticides by LGG and LGR-1 
was further supported by the confirmation of parathion and CP in the bacterial pellets 
following experimentation (Figure 2-3B). The amount of CP observed in LGG pellets 
was considerably higher than LGR-1 pellets. Discrepancy between CP sequestered by 
LGR-1 (Figure 2-3A) and the amount of CP determined in LGR-1 pellets is likely due to 
weak LGR-1-CP binding interactions being perturbed by washing pellets prior to lysis. 
This preferential interaction of LGG, rather than LGR-1, to CP was not observed with 
parathion. Furthermore, disrupting bacterial membranes and surface proteins by using 
methanol as a solvent for binding experiments prevented any notable observations of 
bacterial-organophosphate binding (Figure 2-3C).  
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Figure 2-3. Lactobacilli rhamnosus GG and GR-1 bind, but do not metabolize, 
organophosphate pesticides. 
(A) Percent parathion and CP were determined in stationary phase live and heat-killed 
LGG and LGR-1 cultures relative to pesticide-only controls following 24 h co-
incubations in 50 mM HEPES. (B) Percent maximal parathion and CP bound relative to 
100 ppm input was determined in bacterial pellets following 24 h pesticide co-
incubations 50 mM HEPES. (C) Percent parathion and CP were determined in stationary 
phase chemically-killed LGG and LGR-1 cultures relative to pesticide-only controls 
following 24 h co-incubations in methanol. Data are displayed as means ± SD of at least 
3 independent experiments   * p < 0.05, ** p <0.01, *** p < 0.001. CP = chlorpyrifos, 
LGG = Lactobacillus rhamnosus GG, LGR-1 = Lactobacillus rhamnosus GR-1. 
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2.4.4 L. rhamnosus GG and GR-1 reduced the absorption of 
organophosphate pesticides in a Caco-2 Transwell model. 
The ability of LGG- and LGR-1-mediated organophosphate pesticide sequestration was 
tested for the potential to reduce intestinal absorption of these compounds using a Caco-2 
Transwell model of the small intestine.  LGG and LGR-1 reduced the Caco-2 apical—
basolateral translocation of both parathion and CP compared to unsupplemented controls 
(Figure 2-4). Similar to earlier binding experiments, reduction of organophosphate 
pesticide absorption was more pronounced with LGG compared to LGR-1 and 
lactobacilli binding was more prominent with CP compared to parathion. Basolateral 
levels of parathion increased kinetically (30 min > 60 min > 120 min) post-apical 
exposure for cells exposed to CP with or without supplementation of LGG or LGR-1. 
However, there was an insignificant (other than CP compared to CP-LGG at 1 h) trend of 
decreased basolateral parathion levels in LGG or LGR-1 supplemented cells at all time 
points. Most notably, at 1 h post-apical exposure, CP apical—basolateral absorption was 
undetectable in CP-LGG and CP-LGR-1 simultaneously-treated cells compared to cells 
treated with CP alone. However, by 2 h post-apical exposure basolateral CP levels in CP-
LGG and CP-LGR-1 treated cells increased notably, but remained significantly less (p 
<0.05) than cells treated with CP alone. These findings support earlier observations of 
potentially biologically relevant interactions of probiotic lactobacilli with consumed 
organophosphate pesticides that vary in effect based on subtle differences in molecular 
structure. 
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Figure 2-4. Lactobacillus rhamnosus GG and Lactobacillus rhamnosus GR-1 reduce 
the absorption of organophosphate pesticides in a Caco-2 Transwell model. 
Caco-2 cells, differentiated into small intestinal-like epithelium on Transwells, were 
exposed apically to 100 µM parathion or chlorpyrifos with or without simultaneous 
supplementation with 109 CFU/mL LGG or LGR-1. The basolateral compartment was 
kinetically analyzed for parathion or CP.  Data are displayed as means ± SD from 4 
independent experiments. * p < 0.05, ** p <0.01. CP = chlorpyrifos, ND = not 
detected, LGG = Lactobacillus rhamnosus GG, LGR-1 = Lactobacillus rhamnosus GR-1. 
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2.4.5 L. rhamnosus GG supplementation reduced the toxicity of 
chlorpyrifos to Drosophila. 
Since LGG displayed both the greatest sequestration and reduced in vitro intestinal 
absorption of CP, the ability of oral LGG supplementation to mitigate mortality of 
Drosophila melanogaster lethally exposed to CP-containing food was tested. Adult 
Drosophila were exposed to CP-containing food at various concentrations to determine 
an optimal CP dosage for intervention testing. Drosophila were sensitive to CP-induced 
mortality in a dose-dependent manner (Figure 2-5A) based on median survival of 
Drosophila determined to be: 1 d for 100 µM CP, 3 d for 10 µM CP, and undeterminable 
for 1 µM CP and vehicle. Based on these dose-mortality experiments, the 10 µM CP 
concentration was chosen to investigate the ability of LGG to mitigate acute CP-induced 
mortality. Drosophila that were supplemented with LGG and 10 µM CP had median 
survival comparable to Drosophila receiving just 10 µM CP (both 3 d, Figure 2-5B). 
However, Drosophila simultaneously supplemented with both LGG and 10 µM CP also 
displayed significantly prolonged overall survival (p < 0.0001) and had fewer early time 
point deaths (p < 0.01) than those treated with 10 µM CP alone (Figure 2-5B). Notably, at 
the experimental end point (12 d), 9.901% of Drosophila that were supplemented with 
LGG were still alive; alternatively, 0% of Drosophila exposed to 10 µM CP alone 
survived 10 d post-exposure. These observations suggest that prophylactic priming and 
continual supplementation of Drosophila with LGG may maximize Drosophila survival 
by preventing early time point deaths associated with CP exposure.  
Further experimentation attempted to elucidate if the pro-survival effects observed in CP-
exposed Drosophila supplemented with LGG was due to direct LGG-CP interactions or 
LGG modifying host responses to pesticide toxicity. Drosophila were pretreated with 
vehicle or LGG for 3 d prior to being transferred to media containing 10 µM CP.  No 
overall (p = 0.7064) or early time point (p = 0.4920) survival benefit was observed in 
Drosophila treated with LGG prior to 10 µM CP exposure (Figure 2-5C). Together these 
results suggest that LGG likely interacts directly with CP to mitigate CP-induced toxicity  
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Figure 2-5. Lactobacillus rhamnosus GG supplementation reduces the toxicity of 
chlorpyrifos to Drosophila melanogaster. 
(A) Survival curves of adult Drosophila melanogaster exposed to media containing 1, 10, 
or 100 µM CP or vehicle control. (B) Survival curves of adult Drosophila exposed to 
media containing 10 µM CP with or without simultaneous supplementation of live 
LGG.  (C) Survival curves of adult Drosophila exposed to LGG or vehicle for 3 d, 
following subsequent exposure to media containing 10 µM CP. Data are displayed from 
at least 3 independent experiments. ** p < 0.01. CP = chlorpyrifos, LGG = Lactobacillus 
rhamnosus GG. 
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The direct effect of LGG supplementation on Drosophila microbiota composition and 
physiological responses following 3 d exposure to 1 µM CP (not acutely lethal) were 
further characterized. Since lactobacilli are the dominant member of the Drosophila 
microbiota, lactobacilli were enumerated from Drosophila supplemented with LGG 
with/without simultaneous exposure to 1 µM CP. Both female and male Drosophila 
treated with LGG had significantly higher levels of lactobacilli than Drosophila treated 
with 1 µM CP alone (Figure 2-6A). Although 1 µM CP-treatment did not significantly 
reduce Drosophila lactobacilli levels, lactobacilli levels were notably lower in male flies 
and appeared to display a bimodal response in females (some reduced, some unaffected) 
exposed to CP compared to vehicle controls. Furthermore, female Drosophila exposed 
for 3 d to media containing 1 µM CP and LGG were significantly rescued (p < 0.05) from 
CP-mediated reductions in bodyweight (Figure 2-6B). There was an insignificant trend 
towards similar bodyweight rescue in male flies. Moreover, since CP impacts insect 
locomotion due to exacerbated cholinergic stimulation, the ability of LGG 
supplementation to rescue Drosophila motor deficits following 3 d of 1 µM CP challenge 
was assessed by negative geotaxis assays. However, no differences in Drosophila 
locomotion (distance climbed after 3 s) was observed among treatment groups of vehicle, 
LGG, 1 µM CP, and LGG with 1 µM CP (Figure 2-6C). Together these results suggest 
that: 1) LGG supplementation can enhance the Drosophila microbiota with lactobacilli, 
and 2) low dose 1 µM CP may cause developmental, rather than motor deficits, that can 
be rescued by LGG supplementation.  
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Figure 2-6. Lactobacillus rhamnosus GG promotes body weight gain and lactobacilli 
enhancement in chlorpyrifos-exposed Drosophila, but does not affect locomotion. 
Freshly eclosed Drosophila melanogaster were treated for 3 d with media containing 
vehicle, 1 µM CP, LGG, or 1 µM CP and LGG.  (A) Drosophila bodyweights were 
determined. (B) Surface sterilized Drosophila were homogenized, drop-plated on MRS 
agar, and enumerated for CFU/Drosophila. (C) Drosophila locomotion was tested by a 
negative geotaxis assay in which average fly climbing distance (15-25 flies) of 5 
replicates was quantified after 3 s.  Data are displayed as means ± SEM from at least 3 
independent experiment. * p < 0.05, ** p <0.01, *** p < 0.001. CP = chlorpyrifos, LGG 
= Lactobacillus rhamnosus GG.  
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2.5 Discussion 
Lactobacilli strains were found to grow in high levels of parathion and CP. Since 
commonly used probiotic LGG and LGR-1 displayed unaltered growth in the presence of 
either parathion or CP, we further examined their activity. We showed that the 
organophosphate hydrolase gene, LGG_RS02045, predicted in LGG, was not likely 
responsible for LGG-mediated pesticide degradation. Although, genetic cloning was not 
performed to definitively demonstrate that LGG_RS02045 was non-functional, it was not 
induced by parathion or CP. Furthermore, heat-killed LGG had the same capability to 
sequester parathion and CP from solution as live LGG. This was also found with LGR-1 
and suggests that metabolic activity is not required for bacterial organophosphate 
sequestration in these strains. Thus, unlike Cho et al. (35), we were unable to demonstrate 
degradation of the organophosphate pesticides, parathion or CP, by LGG or LGR-1. 
Differences in our experimental approach compared to the use of fermentation in 
organophosphate-contaminated dairy food products may explain this finding (29, 30). We 
suspect that the higher temperatures (42°C compared to 37°C) and acidic conditions 
present in the in vitro fermentation conditions of other studies could promote pesticide 
breakdown more rapidly.   
The finding of lactobacilli binding to organophosphate pesticides is congruent with 
reports of similar interactions with environmental toxins, such as aflatoxin (24, 25, 36), 
paralytic shellfish toxins (37), and metals (38-41). LGG had a better ability to retain 
organophosphate sequestration—as measured by CP retained in bacterial pellets—of CP 
from solution than LGR-1. This was also found in a Caco-2 Transwell model simulating 
organophosphate absorption in the small intestine. This finding is surprising given the 
genetic similarity between strains. One major difference between LGG and LGR-1 is that 
LGR-1 has a unique exopolysaccharide biosynthesis cluster (unpublished). The ability of 
lactobacilli-derived exopolysaccharide to bind toxins such as lead (41), cadmium (42), 
and aluminum (42) have been described. Furthermore, sediment microbe-produced 
exopolysaccharide has been shown to strongly interact with CP (43, 44). It is interesting 
to speculate that differences in bacterial exopolysaccharide may confer bacterial-
organophosphate binding phenotypes in lactobacilli.  
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Results with Drosophila suggest that dietary supplementation of transitory bacteria can 
be important for conferring host benefits that are not present with the commensal 
microbiota. Specifically, prolonged interaction between CP and LGG lead to increased 
survival. Unlike Drosophila exposed simultaneously to CP and LGG, those pretreated 
with LGG prior to pesticide exposure did not receive a survival benefit. These findings 
further support our hypothesis that LGG supplementation prevents downstream 
organophosphate pesticide toxicity by preventing absorption. Admittedly, we cannot 
completely rule out the possibility that LGG exposure results in priming of host 
detoxification pathways relevant to organophosphate pesticides. Indeed, results from 
Kamaladevi et al. (45) suggest that the survival benefit experienced by CP-challenged 
Caenorhabditis elegans supplemented with L. casei may be due to upregulation of host 
phase-II detoxification genes.   
LGG supplementation was able to significantly rescue weight-loss in female flies 
exposed to 1 µM CP. This trend was also observed in male flies; however, findings were 
not significant. The outcome corresponded with significantly increased lactobacilli 
colony forming units per fly, after treatment with LGG relative to CP alone. 
Lactobacillus are the dominant genus in the Drosophila microbiota and important for 
many host physiological processes (46, 47). We speculate that the supplementation of 
LGG may promote a growth rescue of CP-induced toxicity via stimulation of IMD/Relish 
signaling pathway (48). The IMD/Relish pathway is a central regulator of mediating 
microbiota-mediated host responses in Drosophila and is required for promoting survival 
in response to DNA damage (49). This pathway has been implicated in reducing growth 
to promote maintenance in response to noxious stimuli (49). Alternatively, Lactobacillus 
plantarum isolated from Drosophila has been shown to promote host growth in nutrient 
depleted media via improved protein assimilation (47). Thus, similar to a study by Blum 
et al. (50), we have shown that human probiotic LGG may be capable of conferring 
beneficial effects to host flies in a similar fashion to the native microbiota.  
In summary, this study has shown that the commonly used probiotic organisms LGG and 
LGR-1 are able to bind, but not metabolize, organophosphate pesticides and reduce 
intestinal absorption in vitro. Furthermore, LGG reduced mortality and growth deficits in 
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Drosophila exposed lethally and subchronically to CP, respectively. This work expands 
upon our previous study, which demonstrated L. rhamnosus supplementation could 
reduce heavy metal bioaccumulation in Tanzanian pregnant women (23). Transitory food 
grade bacteria have the potential to act like a non-specific “sponge”—absorbing toxins 
and reducing their uptake by the host. This approach holds promise for supplementing 
human, livestock, or apiary foods with probiotic microorganisms and reducing 
downstream toxicity from organophosphate pesticides. 
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2.9 Supplementary 
Table 2-1. Primers used for qPCR. 
 
 
 
 
 
 
 
 
 
 
 
Gene Forward Primer Sequence Reverse Primer Sequence Efficiency R2 
GyrA CCGYCGAAATGTTACGCGAC GTTGACCAGCAGATTCGGGA 98.83 0.998 
GyrB ATGTCGATGGCGCCCATATT TTTACCTTGACGCAGGCGAT 89.40 0.996 
RecA ACCGAACGACAGGAAGCATT CTCCACTTTGTCCCCCATCC 97.04 0.996 
Php AAGGCTGGTGTGATTGGTGA CCCGTTTCTTTTTGGGCGAT 92.73 0.996 
77 
 
Chapter 3  
3 Lactobacillus rhamnosus supplementation alters low 
dose chlorpyrifos exposure and xenobiotic metabolism 
in a BALB/c mouse model. 
Trinder M, Bisanz JE, McDowell TW, Plé C, McMillan A, Collins SL, Macklaim JM, 
Sumarah MW, Gloor GB, Foligné B, Reid G. 
3.1 Abstract 
The organophosphate pesticide, chlorpyrifos (CP), used in agricultural practices has been 
shown to alter the intestinal microbiota, intestinal barrier function, and hepatic xenobiotic 
metabolism at low doses. We have shown that probiotic Lactobacillus rhamnosus GG 
(LGG) and GR-1 (LGR-1) were able to bind CP and thus reduce CP absorption in a 
Caco-2 intestinal Transwell model and oral toxicity to Drosophila melanogaster. Thus, 
we hypothesized that LGG or LGR-1 supplementation would mitigate low dose CP-
induced early toxicity in a mouse model. Female BALB/c mice were exposed 
subchronically to 2 mg/L of CP via drinking water with daily oral gavage of LGG, LGR-
1, or vehicle. Microbiota analysis by 16S rRNA gene sequencing did not reveal 
differences in fecal microbiota composition throughout the study. Histological 
morphology of the intestine, liver, kidneys, and pancreas and gastrointestinal 
permeability (FITC-dextran assay) were also unperturbed by CP treatment. However, 
comet assays determined that LGG supplementation of CP-treated mice significantly 
reduced colonic and hepatic DNA damage in colon and liver. Hepatic RNA expression of 
toxic insult genes Gadd45a and Atf3 and xenobiotic processing genes Por, Fmo2, and 
Cyp1a1 were significantly altered between treatment conditions. Interestingly, LGR-1, 
but not LGG, supplementation altered early exposure host metabolism of CP. Liquid-
chromatography mass spectrometry determined the CP metabolites 3,5,6-
trichloropyridinol (TCP) and CP-oxon were significantly higher and lower in the urine 
and blood, respectively, after 1 d of oral exposure. To understand LGR-1-mediated 
alteration of CP metabolism, mice were supplemented with only LGR-1 for 3 d prior to 
sacrifice. Gene expression analysis of the liver and intestine revealed that hepatic Por, 
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Fmo2, and Fmo3 were significantly upregulated and intestinal Abcb1a expression was 
altered in LGR-1 treated mice relative to vehicle controls. This study provides 
preliminary insight into the interactions between food-grade microbes and host 
xenobiotic metabolism and how microbial supplementation could enable targeted 
pharmacology and preventative toxicology. 
3.2 Introduction 
Pesticide usage has been questioned for both environmental and human safeties. The 
organophosphate insecticide, chlorpyrifos (CP), is commonly used in agriculture for 
treating fruit and vegetable vineyards and fruit orchards. Consequently, humans and 
wildlife are often exposed to low oral doses of CP through the consumption of 
contaminated food and drink. Despite the fact that many toxicology studies use CP levels 
that far exceed food source contamination, clinical correlations suggest that low dose 
organophosphate pesticide exposure may induce subtle detrimental changes to human 
physiology which lead to chronic disease (1-5). 
Microorganisms that inhabit the gastrointestinal tract of mammals, commonly referred to 
as the microbiota, have been shown to be disturbed by conventionally “safe” xenobiotics 
such as emulsifiers (6), artificial sweeteners (7), antibiotics (8), and pesticides (9). 
Moreover, evidence from heavy metal exposed germ-free mice suggests the microbiota 
plays an underappreciated role in mitigating toxic outcomes (10). Culture-based 
microbial identification demonstrated that CP-induced microbiota shifts in both an in 
vitro chemostat model of the intestinal tract, in rats (9) and mice (11). Taken together, 
these studies suggest that understanding the interplay between xenobiotics and the 
microbiota may improve preventive therapies that target the links between environmental 
toxin exposure and chronic diseases associated with xenobiotics such as pesticides. It is 
anticipated that the interplay between the microbiota and pharmacology/toxicology will 
help future medical professionals improve the morbidity and economic burden of chronic 
diseases. 
Bioremediation has been well-researched for several decades and has shown that bacteria 
can remove environmental toxins such as organophosphate insecticides from 
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contaminated environments (12) . We have attempted to expand on this concept in vivo 
by using transitory probiotic microorganisms as sinks for organophosphate pesticides 
entering into the gastrointestinal tract (13). Lactobacillus brevis WCP902 has been shown 
to contain the organophosphate hydrolase gene, OpdB, required for metabolism of 
organophosphate pesticides (14). However, many strains of Lactobacillus have been 
shown to reduce the levels of organophosphate pesticides in dairy products ex vivo (15, 
16), suggesting a more generic mechanism of action may also exist. We have shown that 
the commonly used probiotics Lactobacillus rhamnosus GG (LGG) and Lactobacillus 
rhamnosus GR-1 (LGR-1) were able to bind and sequester CP from solution. We further 
demonstrated that LGG was able to reduce the absorption of CP in a Caco-2 Transwell 
model of intestinal absorption and prolong the survival of Drosophila melanogaster 
lethally exposed to CP (Trinder et al., submitted 2016). These findings of a binding 
interaction between probiotic Lactobacillus organisms and an environmental toxin are 
similar to studies of the relationship between lactobacilli and aflatoxin (17), shellfish 
toxins (18), and metals.  
Low-dose oral pesticide exposure is currently an unavoidable consequence of 
industrialized society and food production requirements to meet the demands of human 
overpopulation. Interestingly, LGG and LGR-1 are well-documented probiotic organisms 
that have been shown to oppose many of the CP-induced pathologies such as promoting 
intestinal health by enhancing intestinal barrier function (19), mitigating microbiota 
dysbiosis (20), and binding CP and mitigating intestinal absorption and downstream 
toxicity. Thus, we hypothesized that daily Lactobacillus rhamnosus supplementation 
would mitigate toxic insults to the gastrointestinal tract and associated microbiota of mice 
exposed sub-chronically to environmentally relevant levels of CP.  
3.3 Methods 
3.3.1 Animals 
Six-week-old female BALB/c mice (Charles River Laboratories) were randomly divided 
into treatment groups and housed in a controlled environment (with a temperature of 
22°C, a 12h/12h light/dark cycle and ad libitum access to food and water). Animal 
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experiments were performed in accordance with the guidelines issued by the Animal Use 
Subcommittee at Western University (protocol number 2015-039) in accordance with the 
Canadian Council of Animal Care or the Institut Pasteur de Lille’s Animal Care and Use 
Committee, which are based on the Amsterdam Protocol on Animal Protection and 
Welfare and Directive 86/609/EEC on the Protection of Animals Used for Experimental 
and Other Scientific Purposes, updated in the Council of Europe's Appendix A. The 
animal experiments also complied with French legislation (Government Act 87-848) and 
the European Communities Amendment of Cruelty to Animals Act 1976. All studies 
were approved by the local investigational ethics review board (Nord-Pas-de-Calais 
CREEA 75, Lille, France; protocol numbers 192009R and 042011).  
3.3.2 Bacterial culture conditions 
LGG and LGR-1 were routinely inoculated from lactobacilli de Man, Rogosa and Sharpe 
(MRS) agar (BD, catalog number: 288130) plates into MRS broth. Inoculated MRS broth 
cultures were subcultured (1:100 dilution) and incubated overnight (18 h) at 37° statically 
and anaerobically. Cultures were pelleted at 5000 g (10 min), washed with sterile normal 
saline, and concentrated 10-fold in sterile normal saline (1010 CFU/mL). 
3.3.3 Subchronic experimental design 
Mice were randomized into treatment groups that included: vehicle, CP, CP and LGG, or 
CP and LGR-1. CP (Sigma-Aldrich, 45395) stock solutions were made at 100 mg/mL in 
dimethyl sulfoxide (Sigma-Aldrich) and stored at -20°C. CP was dissolved into opaque 
water bottles at a concentration of 2 mg/L of water. Drinking water was replaced every 3 
d. Mice received daily oral gavage of normal saline, 109 CFU LGG, or 109 CFU LGR-1. 
Whole blood and urine were collected from mice at 1 and 24 d (endpoint) post-CP 
exposure by retro-orbital bleed and gentle bladder compression, respectively. Fecal 
samples were collected from mice 1 d prior, 1 d post, and at the endpoint of CP exposure.  
Separate mice were randomized into vehicle, CP, CP and LGG and used for the FITC-
dextran permeability and comet assays. Mice were euthanized by cervical dislocation and 
immediately dissected for organ collection. Samples were stored at -80°C until analysis 
unless otherwise stated. 
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3.3.4 Acute Lactobacillus rhamnosus GR-1 experimental design 
Mice were randomized into treatment groups consisting of daily oral gavage of normal 
saline or 109 CFU LGR-1 for 3 d. On the 4th day, mice were anesthetized by isoflurane 
inhalation and subsequently euthanized by cervical dislocation. Blood was immediately 
collected by cardiac puncture and organs were dissected, washed in 0.01 M PBS, and 
flash frozen with liquid nitrogen. Samples were stored at -80°C until analysis unless 
otherwise stated. 
3.3.5 FITC-dextran gastrointestinal permeability assay 
Mice received 12 mg (200 µl of 600 mg/kg) of fluorescein isothiocyanate conjugated 
dextran (FITC-dextran, average mol wt 3000-5000 Da; Sigma-Aldrich, Saint-Louis, 
Missouri) by oral gavage. Blood was collected by retro-orbital puncture 4 hours after 
administration. Blood samples were centrifuged and sera were collected. Concentration 
of FITC-dextran was determined by spectrophotofluorometry with an excitation 
wavelength of 485 nm and an emission wavelength of 520 nm.  
3.3.6 Comet assay 
Comet assays were used to assess DNA damage of tissues. Immediately after dissection, 
colons and livers were minced using fine scissors and intestinal cells were scrapped, both 
in cold mincing buffer (Mg2+- and Ca2+-free Hanks’ balanced salt solution (Gibco, CA, 
USA) with 20 mM EDTA (Sigma-Aldrich) and 10% DMSO (Sigma-Aldrich)). After 
centrifugation, cells were counted and cell suspensions (2 x 104 cells) were mixed with 
75 µL of 0.5% low-melting point agarose before rapidly transferring onto pre-coated 
slides (two layers of normal agarose: 1.5% and 0.8% respectively). All of the following 
steps were sheltered from daylight to prevent the occurrence of additional DNA damage. 
Slides were immersed overnight at 4°C in cold lysis solution (2.5 M NaCl, 100 mM 
Na2EDTA, 10 mM Tris-base, 10% DMSO, 1% Triton-X100). After lysis, slides were 
placed in electrophoresis solution (1 mM Na2EDTA, 0.3 M NaOH (pH>13)) for 20 min 
to allow for DNA unwinding. Subsequently, electrophoresis was conducted at 25 V for 
20 min. Slides were immersed in a neutralization solution (0.4 M Tris-base, pH 7.5) for at 
least 5 min and dehydrated with absolute ethanol for 5 min. Cells were stained with 
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propidium iodide (20 µg/ml). All slides were independently coded before the microscopic 
analysis. Comet was observed via fluorescence microscope (Leica Microsystems SAS-
DM 2000, Heerbrugg, Switzerland) at magnification of 200x and analyzed by COMET 
ASSAY IV software (Perceptive Instruments, UK).  For each sample, 50 comets/slide 
were analyzed, with 3 slides scored/sample. 
3.3.7 Histology 
Samples for histological analysis were fixed in 4% formaldehyde, dehydrated and 
embedded in paraffin. Sections (4-7 µm thick) were stained with hematoxylin and eosin 
or Periodic Acid Schiff with 1% Light Green SF counterstaining.  
3.3.8 RNA extraction, reverse transcription, and qPCR 
Dissected tissues were stored in RNAlater at -20°C until extraction. Tissues were 
homogenized in TRIzol reagent (Life Technologies) using a Pellet Pestle (Kimble 
Chase).  After phase separation with chloroform according to the manufacturer’s 
protocols, the aqueous phase was combined with 100% ethanol and purification 
continued with the PureLink RNA Mini Kit (Ambion, catalog number: 12183025) with 
on-column treatment of PureLink DNase treatment (Ambion, catalog number: 
12185010). RNA quantity and purity was assessed with a NanoDrop ND-1000 
spectrophotometer (Thermo Scientific). RNA integrity was confirmed by Bioanalyzer 
analysis (Agilent Technologies) when required. RNA was stored at -80°C until reverse 
transcription. 
cDNA was prepared from 200-2000 ng of purified total RNA using a High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, catalog number: 4368813). qPCR 
was performed with a 7900HT Sequence Detection System (Applied Biosystems) in 20 
µL reactions using Power SYBR Green Master Mix (Applied Biosystems, catalog 
number: 4368702) with 200 µM of appropriate forward and reverse primers. Primers used 
for qPCR analysis are listed in Supplementary Table 3-1. qPCR results were analyzed 
using SDS RQ 6.3 manager software (Applied Biosystems) and relative gene expression 
was calculated using the 2−ΔΔct method. Microarrays were prepared and analyzed as 
before (21) with the Affymetrix Mouse Gene 2.0 ST array platform. 
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3.3.9 Microbial DNA extraction, sequencing, and community 
analysis 
Fecal samples were stored in RNAlater at -20°C until DNA extraction was 
performed with MoBio PowerSoil 96-Well Soil DNA Isolation Kits (Carlsbad, 
CA) according to the modified Earth Microbiome Project standard protocols. A 
single fecal pellet (approximately 30 mg) was extracted per sample. The V4/V5 
region of the 16S ribosomal RNA gene was PCR amplified with 
bacterial/archaeal primers 515F and 806R according to previously described 
methods (22) and modified for the Illumina MiSeq platform.  
Amplicons were quantified using Picogreen (Quant-It; Life Technologies, Burlington, 
ON), pooled at equimolar concentrations before cleanup (QIAquick PCR clean up; 
Qiagen, Germantown, MD), and sequenced using the MiSeq by Illumina platform, with 2 
x 220 paired-end chemistry at the London Regional Genomics Centre at Robarts 
Research Institute (Western University, London, ON). Reads were quality filtered, 
overlapped with Pandaseq, and binned into operational taxonomic units (OTUs) using 
closed-reference OTU picking based on 97% identity using the SILVA reference 
database. 
Open-source QIIME software was used for generation of weighted UniFrac principal 
coordinate analysis (PCoA) for exploratory data analysis (23). Distance on PCoA plot 
represents overall dissimilarity between the microbiota profiles of samples using 
weighted UniFrac phylogenetic distance. Assessment of differentially abundant genera 
were determined using ALDEx2 v1.0.0 in R with unpaired Welch's t tests with Benjamini 
Hochberg's false discovery rate (FDR) method with a q < 0.05 cutoff (24). 
3.3.10 Blood and urine sample preparation for targeted liquid-
chromatography mass spectrometry 
One volume of whole blood was extracted with 2 volumes of ice cold methanol to 
precipitate proteins. Supernatants were collected following centrifugation at 14 000 g for 
15 min. Urine was diluted 10-fold with methanol.  
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3.3.11 Liver sample preparation for untargeted liquid-
chromatography mass spectrometry 
Livers samples were thawed on ice. Samples were supplemented with 5 µL and 2 mg of 
acetonitrile and Ottawa sand (Fisher Scientific) per mg of tissue, respectively. Samples 
were homogenized for 5 cycles using a FastPrepTM FP120 Cell Disrupter (Thermo 
Savant) set to speed 4 for 20 s/cycle. Samples were stored on ice for at least 1 min 
between a series of 5 cycles. Homogenates were centrifuged at 14 000 g for 5 min. 
Supernatants were dried down and stored at -80°C until analyses. Immediately prior to 
sample analysis, samples were resuspended with an equal volume of high performance-
liquid chromatography (HPLC) grade water containing 0.05 g/mL 6C13 phenylalanine 
internal standard (Cambridge Isotopes, Tewksbury, USA). 
3.3.12 CP, CP-oxon and TCP liquid-chromatography mass 
spectrometry 
An Agilent 1290 Infinity HPLC coupled to a Q-Exactive Orbitrap mass spectrometer 
(Thermo Fisher Scientific, Waltham, USA) with a HESI (heated electrospray ionization) 
source. Two µL of each sample was injected into a ZORBAX Eclipse plus C18 2.1 x 
50mm x 1.6 micron column. Mobile phase (A) consisted of 0.1% formic acid in water 
and mobile phase (B) consisted of 0.1% formic acid in acetonitrile.  The initial 
composition of 0% (B) was held constant for 1.5mins and decreased to 100% over 3.0 
minutes. Mobile phase B was then held at 100% for 1.5 minutes and returned to 0% over 
30 seconds, re-equilibrated at 0% (B) for 1 minute for a total run time of 7.5 min. 
3.3.13 Mass spectrometry positive mode CP and CP-oxon liquid 
chromatography-mass spectrometry analyses 
The HESI source was operated under the following conditions: nitrogen flow of 20 and 
15 arbitrary units for the sheath and auxiliary gas respectively, probe temperature and 
capillary temperature of 460 °C and 400 °C respectively and spray voltage of 3.25 
kV.  The S-Lens was set to 60.  A top 5 data dependent MS2 (ddMS2) was conducted at a 
full MS scan between the ranges of m/z 100-1000 in positive mode at 70 000 resolution 
(AGC target and maximum injection time were 3e6 and 250 ms respectively) and 
MS/MS at 17,500 resolution, normalized collision energy set to 30 (AGC target and 
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maximum injection time of 1 x 105 and 100 ms, respectively).  
3.3.14 Mass spectrometry negative mode TCP liquid 
chromatography-mass spectrometry analyses 
The HESI settings were optimized for TCP in negative mode with the following 
values.  Nitrogen flow of 20 and 5 arbitrary units for the sheath and auxiliary gas 
respectively, probe temperature and capillary temperature of 455 °C and 400 °C 
respectively and spray voltage of 3.50 kV.  The S-Lens was set to 40.  The ddMS2 
experiment was equivalent to the CP with the mass range adjusted to 70–700 m/z. 
3.3.15 Statistical analyses 
Unless otherwise stated, all statistical analyses were performed in GraphPad Prism 6 
using unpaired t or Mann-Whitney tests for comparison of 2 groups. Alternatively, for > 
2 groups one-way ANOVA with Tukey’s multiple comparisons test or Kuskal-Wallis test 
with Dunn’s multiple comparisons test were used. 
3.4 Results 
3.4.1 Subchronic chlorpyrifos does not alter general mouse 
behavior or gross intestinal, pancreatic, or kidney 
architecture 
To assure that experimental results obtained were not a result of different pesticide-
contaminated water consumption among treatment groups, food and water intake and 
bodyweight changes were monitored. Throughout the study, treatment groups 
demonstrated no significant differences in food or water consumption or bodyweight 
changes (Supplementary, Figure 3-6). Studies have started to report on the toxic effects 
of conventionally safe xenobiotics such as emulsifiers (6) and artificial sweeteners (7) to 
the microbiota and gastrointestinal tract. Similarly, it was investigated if CP could induce 
any gross changes to gastrointestinal morphology. No notable histological abnormalities 
were observed in the intestine among treatment groups. Duodenal (Supplementary, 
Figure 3-7), jejunal (Supplementary, Figure 3-8), and colonic (Supplementary, Figure 3-
9) mean: villus length, villus width, lamina propria width, mucin+ cells/mm2 of villus, 
inner muscle width, and outer muscle did not differ with CP treatment. These results 
86 
 
suggest that subchronic CP exposure does not alter gross intestinal morphology in mature 
mice at low doses (2 mg/L). 
3.4.2 Chlorpyrifos does not alter intestinal membrane integrity, but 
does induce colonic DNA damage, which is mitigated by 
Lactobacillus rhamnosus GG 
Since CP has been reported to induce gastrointestinal permeability (25) and DNA 
damage, we sought to evaluate the protective effect of LGG supplementation on these 
insults. However, with our dosing scheme no difference in gastrointestinal membrane 
permeability was observed in mice treated with CP or CP with LGG relative to vehicle 
controls (Figure 3-1A). In contrast, assessment of colonic DNA damage by comet assay, 
suggested that CP increased intestinal DNA damage (Figure 3-1B). This increase in CP-
induced colonic DNA damage was significantly reduced (p < 0.05) by LGG 
supplementation. These findings suggest that LGG supplementation may protect against 
innate DNA damage present in colonic tissue in healthy non-toxically-challenged 
animals.  
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Figure 3-1. Chlorpyrifos does not alter intestinal membrane integrity, but does 
induce colonic DNA damage, which is mitigated by Lactobacillus rhamnosus GG. 
Mouse (A) gastrointestinal membrane integrity and (B) colonic DNA damage were 
assessed at experimental endpoint of subchronic exposure by FITC-dextran permeability 
(n = 8) and comet assays (n = 5), respectively. Data are expressed as means ± SD. * p < 
0.05. CP = chlorpyrifos, LGG = Lactobacillus rhamnosus GG. 
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3.4.3 Chlorpyrifos exposure does not alter fecal microbiota 
composition 
Studies have shown that commonly consumed xenobiotics such as emulsifiers (6) and 
artificial sweeteners (7) may be associated with chronic metabolic diseases due to 
changes to the gastrointestinal microbiota. Other studies have shown that CP can induce 
community shifts in the gastrointestinal microbiota at relatively high doses (9, 11). This 
study explored if low dose (non-bolus) sub-chronic CP exposure could alter microbiota 
profiles in young adult mice. Longitudinal weighted UniFrac analysis of the fecal 
microbiota composition is depicted as a cross-sectional representation of each time point 
(Figure 3-2). The lack of any definitive clustering of samples by treatment group at any 
time point suggests that there is no clear effect of low dose CP exposure on gross fecal 
microbiota composition. Furthermore, quantification of differentially abundant OTUs 
between vehicle- and CP-treated mice using AldEx2 demonstrated that no significantly 
distinct taxonomic differences existed among treatments. These results indicate that 
unlike a bolus oral dose of pesticide (11, 26), sustained exposure appears to have a less 
drastic effect on gastrointestinal microbiota composition.  
89 
 
 
Figure 3-2. Low dose chlorpyrifos exposure does not alter fecal microbiota 
composition. 
3D weighted UniFrac PCoA illustrate the microbiota among the different mouse fecal 
samples 1 d prior to pesticide exposure (d -1), 1 d post-pesticide initiation (d 1), and at the 
experimental endpoint (d 24). The following UniFrac PCoA analyses were based on the 
OTU data, with only the percent variance explained of the first three principal coordinates 
shown. CP = chlorpyrifos, LGG = Lactobacillus rhamnosus GG, LGR-1 = L. rhamnosus 
GR-1.  
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3.4.4 Hepatic response to low dose chlorpyrifos with and without 
Lactobacillus rhamnosus intervention 
CP is rapidly metabolized by the liver into active/toxic (CP-oxon) and non-active 
secondary metabolites. Given that the liver is the major site of CP metabolism, this study 
sought to investigate the effect of CP on hepatic morphology and gene expression of 
enzymes involved in toxin-induced stress and CP metabolism. Gross hepatic histological 
morphology appeared largely unaltered by CP treatment with or without LGG or LGR-1 
supplementation (Figure 3-3A). Alternatively, hepatic DNA damage decreased in order 
of vehicle > CP > CP + LGG. Hepatic tissues from mice receiving CP and LGG 
supplementation had significantly (p < 0.01) less DNA damage than vehicle controls 
(Figure 3-3B). Gene expression of several genes involved in the toxic gene response 
network to DNA damage were altered by our experimental treatment conditions (27). 
Egr1 (insignificant) and Gadd45a (p < 0.05) were upregulated in mice treated with CP 
and LGG or LGR-1, but not CP alone (Figure 303C). Furthermore, Atf3 was significantly 
(p <0.05) downregulated in mice treated with CP and LGR-1 relative to mice treated with 
CP only. Alternatively, the key cytochrome P450 (Cyp) regulator, Por, was significantly 
(p < 0.05) upregulated in CP, CP and LGG, and CP and LGR-1 groups relative to vehicle 
controls. Furthermore, mice receiving CP with LGG had significantly (p <0.05) 
upregulated Fmo2 and Cyp1a1 expression compared to vehicle- and CP-treated animals, 
respectively (Figure 3-3D). Together these results suggest that low dose CP exposure can 
affect early host toxin response genes and hepatic xenobiotic processing, some of which 
appear to be modified by L. rhamnosus supplementation.  
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Figure 3-3. Hepatic response to chlorpyrifos with/without Lactobacillus rhamnosus. 
 (A) No notable gross histological abnormalities were observed in the liver. Scale bar = 
1000 µm. (B) Hepatic DNA damage was assessed by comet assay (n = 5, means ± SD). 
Relative hepatic gene expression was evaluated for (C) toxic response and (D) xenobiotic 
metabolism genes. Relative gene expression of target genes was normalized to beta-actin 
and expressed as means ± SEM (n = 5-8). * p < 0.05, ** p < 0.01, *** p < 0.001. CP = 
chlorpyrifos, LGG = Lactobacillus rhamnosus GG, LGR-1 = L. rhamnosus GR-1. 
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3.4.5 Lactobacillus rhamnosus GR-1 supplementation alters host 
chlorpyrifos metabolism 
Previous work demonstrated that LGG and LGR-1 were able to bind and sequester CP 
from solution, reduce CP absorption in a Caco-2 Transwell model of intestinal 
absorption, and prolong the survival of Drosophila melanogaster lethally exposed to CP 
(Trinder et al., submitted 2016). Therefore, it was predicted that LGG and LGR-1 
supplementation would reduce oral CP absorption in mice. At 1 d post-CP exposure, 
mice receiving CP with LGR-1 supplementation displayed significantly (p <0.05) lower 
levels of urine CP-oxon and higher levels of blood TCP, respectively (Figure 3-4). This 
finding suggests that LGR-1 is priming the murine host’s ability to metabolize initial CP 
exposures more efficiently or through less toxic metabolic pathways. As a consequence, 
mice receiving LGR-1 displayed lower excretion of the toxic CP-oxon metabolite and 
higher blood levels of the end CP metabolite TCP. Alternatively, urine TCP 
concentration was also observed to be significantly greater (p < 0.01) than CP only 
treated animals at the d 24 experimental endpoint, but not d1 (Figure 3-4).  However, 
blood TCP concentrations did not differ significantly between treatment groups at the d 
24 experimental endpoint (Figure 3-4). This observation is congruent with LGR-1-
mediated modifications in host CP metabolism seen at early d 1 post-exposure. It is 
important to note that the levels of CP-oxon (other than d 1 urine) and CP were not 
detectable throughout the experiment and makes conclusive interpretation of results 
challenging. In general, these results suggest that LGR-1, but not LGG, may modify how 
hosts metabolically respond to low levels of CP. 
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Figure 3-4. Mice supplemented with Lactobacillus rhamnosus GR-1 display altered 
initial chlorpyrifos metabolism at 1 d post-exposure. 
Levels of 3,5,6- trichloropyridinol (TCP) and CP-oxon were quantified in the blood and 
urine of mice by liquid-chromatography mass spectrometry. Data are expressed as means 
± SD (n = 5-8). *p<0.05, **p<0.01. CP = chlorpyrifos, LGG = Lactobacillus rhamnosus 
GG, LGR-1 = Lactobacillus rhamnosus GR-1. 
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3.4.6 Lactobacillus rhamnosus GR-1 modulates hepatic 
defensome transcription 
Based on altered CP metabolite profiles in mice supplemented with LGR-1, but not LGG, 
we further characterized the host xenobiotic transcriptional response in the duodenum, 
liver, and kidneys of mice receiving acute exposure to LGR-1 by microarrays. The 
hypothesis was that altered CP metabolism observed in LGR-1-treated mice was a result 
of modified xenobiotic metabolism in the liver, small intestine, or kidneys of these 
animals. Genes from microarray analysis that were determined to be significantly 
differentially expressed (p<0.05, ±2-fold) were subjected to GO enrichment analysis, 
which revealed that xenobiotic metabolic processes were significantly enriched (p<0.05) 
in the liver but not the small intestine or kidney. Confirmation of microarray hits in the 
liver by qPCR, revealed that LGR-1 significantly upregulated (p <0.05) Por, Fmo2, and 
Fmo3 expression (Figure 3-5A). However, expression of many Cyp enzymes relevant to 
CP metabolism—Cyp1a1, Cyp2b10, Cyp3a41b, Cyp27b1—were found to be unaltered 
by LGR-1 supplementation. The major drug efflux pump ABCB1A, which is responsible 
for effluxing CP from the intestine to prevent absorption, was shown to be modulated by 
LGR-1 in a site-specific manner along the intestinal tract (Figure 3-5B). LGR-1 
supplementation enhanced Abcb1a gene expression in the duodenum and jejunum, but 
significantly down regulated colonic expression (p < 0.01). Hence, LGR-1 
supplementation appears to modulate transcription of host xenobiotic response processes 
in the liver and intestine. The consequence of these changes may have far reaching 
consequences to understanding how microbes can be used to manipulate drug and toxin 
(such as CP) exposures in humans.  
In an effort to explain the mechanism of how LGR-1 modified host xenobiotic 
metabolism, we cultured lactobacilli from the feces of mice and performed untargeted 
metabolomics on the liver and plasma of mice at the experimental endpoint. Gene 
expression changes induced by LGR-1 were correlated with a significant enrichment (p < 
0.01) of the culturable fecal microbiota with lactobacilli species that were predominately 
LGR-1 (Figure 3-5C). However, metabolomic analysis of the liver was unable to identify 
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a differentially abundant metabolite that could mechanistically explain the altered hepatic 
xenobiotic metabolism following LGR-1 supplementation (Figure 3-5D). Since the 
metabolomic analyses were performed 24 h post LGR-1 exposure, it is possible that the 
metabolite analyses missed the time point in which LGR-1 had notable effects on the host 
plasma and hepatic metabolome. Future work plans to definitively determine the 
mechanism and functional consequences of LGR-1-mediated transcriptional changes to 
host xenobiotic metabolism processes.  
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Figure 3-5. Lactobacillus rhamnosus GR-1 alters hepatic xenobiotic metabolism. 
Gene expression in the (A) liver and (B) intestine of mice treated for 3 d with L. 
rhamnosus GR-1 (LGR-1) or vehicle control were evaluated by SYBER Green qPCR. 
Relative gene expression of target genes were normalized to beta actin and expressed as 
means ± SEM (n=7). (C) Fecal pellets were collected longitudinally from mice 5 h post-
LGR-1 supplementation and plated on MRS agar for enumeration of lactobacilli (n = 9, 
means ± SEM). (D) Principal component analysis of negative mode liquid-
chromatography mass spectrometry of the hepatic metabolite abundance data obtained 
from mice receiving vehicle or LGR-1 treatment (only variance of first two components 
shown). * p<0.05, ** p < 0.01, *** p < 0.001. LGR-1 = Lactobacillus rhamnosus GR-1. 
Cy
p2
b1
0
Fm
o2
Fm
o3
Gs
tm
3
Il1
β Po
r
Cy
p1
a1
Cy
p1
a2
Cy
p2
b7
b1
Cy
p3
a4
1b
Gc
lc
Gs
s
0
2
4
6
8
10
12
14
16
Gene
Re
la
tiv
e 
he
pa
tic
 g
en
e 
ex
pr
es
si
on
 
(n
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
Vehicle
LGR-1
*
*
*
Ve
hic
le
LG
R-
1
0
2
4
6
8
Re
la
tiv
e 
du
od
en
al
 A
bc
b1
a 
ex
pr
es
si
on
(n
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
Ve
hic
le
LG
R-
1
0
2
4
6
8
Re
la
tiv
e 
je
ju
na
l A
bc
b1
a 
ex
pr
es
si
on
(n
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
Ve
hic
le
LG
R-
1
0.0
0.5
1.0
1.5
2.0
2.5
Re
la
tiv
e 
co
lo
ni
c 
Ab
cb
1a
 e
xp
re
ss
io
n
(n
or
m
al
iz
ed
 to
 b
et
a-
ac
tin
)
**
MRS agar
0 1 2 3
9.0
9.5
10.0
10.5
11.0
11.5
12.0
Days
CF
U/
g 
of
 fe
ce
s 
(lo
g1
0)
Ctrl
LGR-1
**** ***
A)
B)
C) D)
●
−30 −20 −10 0 10 20
−3
0
−2
0
−1
0
0
10
Individuals factor map (PCA)
Dim 1 (29.60%)
Di
m
 2
 (1
2.
44
%
)
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Control
GR−1
97 
 
 
3.5 Discussion 
Unlike most other oral CP toxicology studies that utilize daily oral gavage of several 
mg/kg of CP (26), mice in this study were exposed to chlorpyrifos through ad libitum 
access to water contaminated with 2 mg/L of CP.  Although this approach provides a 
more environmentally-relevant simulation of human and wildlife CP-exposure, CP has 
been shown to demonstrate increased degradation in aqueous solution with increasing 
pH, radiation frequency, water quality, and temperature. However, the half-life of CP at 
water concentrations of 1-2 mg/L has been reported to be approximately 41 d (28). As an 
extra precaution to mitigate any potential confounding aqueous CP degradation, mouse 
water bottles contained neutral pH tap water, water bottles were protected from light, and 
water bottles were replaced with fresh water every 3 d.  
Also, unlike other mouse studies evaluating the toxic properties of CP, we did not 
observe the drastic CP-induced histological pathology, increased intestinal membrane 
permeability (25), and/or microbiota disturbances (9, 11, 26). There could be several 
explanations to these discrepancies such as CP dosage (other studies used daily 1 mg/kg 
CP bolus gavage versus this studies ad libitum access to contaminated 2 mg/L CP in 
drinking water), developmental time point of CP exposure, experimental duration, and 
animal model susceptibility to CP toxicity. In general, neonatal organisms are well-
known to be more susceptible to toxic insult. With particular relevance to 
organophosphate pesticides, adult rats have been shown to be more resistant to parathion 
and CP toxicity due to higher levels of hepatic aliesterase and Cyp450 dearylation (29). 
This reasoning could explain why Condette et al. (26) observed intestinal histological and 
microbiota impairments in rat pups with  perinatal exposure to CP, while this study did 
not. Despite no obvious differences in hepatic histology among treatment groups, this 
study observed that hepatic DNA damage among treatment groups decreased in order of 
vehicle > CP > CP with LGG. Furthermore, genes involved in CP xenobiotic metabolism 
were largely unchanged among treatment groups (30), while the early onset drug-induced 
toxicity network appeared dysregulated (27).  LGG upregulated Egr1 and Gadd45a (p < 
0.05) in mice that received CP with LGG or LGR-1, but not CP alone. On the other hand, 
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hepatic Atf3 was significantly downregulated (p < 0.05) in mice receiving CP and LGR-1 
relative to CP alone. These findings suggest that Lactobacillus rhamnosus 
supplementation may mitigate anti-apoptotic effects that have been reported following 
low dose CP exposures to human (30). The direct consequences of these results on 
hepatic function remain unclear, but suggest that L. rhamnosus supplementation may 
improve host pesticide detoxification.  
Mice that were exposed to LGR-1 were found to have significant alterations in blood and 
urine CP metabolites, CP-oxon and TCP, relative to mice exposed to CP alone or CP with 
LGG. Notably, the metabolite levels were extremely low. Interpretation of these findings 
is challenged by the fact that the parent compound, CP, was unable to be detected in 
blood or urine samples. However, this finding is not surprising given low dose exposure 
and the sensitivity of CP to host xenobiotic metabolism following oral exposure (31).  
Blood CP levels have been shown to be rapidly metabolized into TCP in rats 3 h after 
oral gavage (32). Interestingly, CP metabolism was altered in mice that received 
supplementation with LGR-1, but not LGG. This finding is surprising given the genetic 
similarity between strains. One major difference between LGG and LGR-1 is that LGR-1 
has a unique exopolysaccharide biosynthesis cluster (unpublished). Thus, it is possible 
that the immune-xenobiotic metabolism axis is differentially regulated in response to 
strain-specific cell surface moieties (33).  
We showed that acute supplementation of BALB/c mice with LGR-1 can alter host 
hepatic defensome gene expression. Although previous work used germ-free animals to 
show that the microbiota is critical to host xenobiotic metabolism (8, 34-37), very few 
studies have characterized the various effects of individual species or strains in a non-
sterile host (34, 38). These latter findings have important translational implications to 
human pharmacology and toxicology. The observations of significantly upregulated 
hepatic P450 oxidoreductase (Por), flavin containing monooxygenase 2 (Fmo2), and 
Fmo3 is interesting given the context of this study to organophosphate pesticides. Por 
catalyzes the transfer of electrons to all Cyp450 (Cyp) enzymes, and consequently is 
important to xenobiotic (39, 40) and toxin (41) metabolism in vivo. Rodent homologues 
for human CYP2C9, CYP2C19, CYP2B6, and CYP3A4 have been shown to be critical 
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for CP metabolism.  In particular, the activities of human CYP2C19 and CYP2B6 have 
been implicated in CP detoxification and toxicity, respectfully (42). Therefore, it is 
interesting to speculate on how LGR-1 modulation of Por may alter Cyp-mediated 
metabolism of not just CP, but other xenobiotics. 
The current mechanism of how LGR-1 supplementation modulates host xenobiotic 
metabolism is unknown. Venkatesh et al. (43) reported that the microbiota can modulate 
hepatic xenobiotic metabolism via production of small molecules that can interact with 
the pregnane X receptor, which is a  key xenobiotic sensor responsible for Cyp induction. 
In contrast to the small molecule hypothesis supported by Venkatesh et al. (43), 
untargeted metabolomics analysis of liver and plasma samples from mice treated with 
LGR-1 or vehicle failed to identify any small molecules significantly altered in 
abundance. Alternatively, LGR-1 supplementation could be modulating hepatic activity 
by microbiota-dependent crosstalk between the immune system and xenobiotic 
metabolism (44-46). Xenobiotic metabolism regulation has been associated with 
microbial recognition  receptors Toll-like receptor 2 (47) and Toll-like receptor 4 (43). 
Although studies evaluating the global immune response to LGR-1 supplementation in 
vivo are limited, LGR-1 interacts with immune cells through the alteration of granulocyte 
colony-stimulating factor (48, 49). Future work in selectively-colonized germ-free 
animals would help to better characterize the problems associated with deciphering the 
effect of exogenous microbial supplementation on the physiology of a non-sterile host.  
In summary, this study has shown that sub-chronic exposure to environmentally-relevant 
levels of CP may not be as toxic as anticipated in non-neonatal mammals. The observed 
alteration in CP metabolism by LGR-1 supplementation was correlated to enhanced gene 
expression of Por and Fmo2. These observations highlight the underexplored interaction 
between consumed microbes and host xenobiotic metabolism. Notably, the findings 
warrant further functional study and mechanistic characterization. That being stated, this 
study provides preliminary insight into how targeting the microbiota with probiotics, 
prebiotics, or synbiotics could be used to optimize pharmacotherapy or mitigate toxin 
exposures.    
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3.7  Supplementary 
 
Figure 3-6. Lactobacilli and/or low levels of chlorpyrifos do not alter mouse water or 
food consumption or bodyweight. 
Cumulative (A) water and (B) food consumption and (C) bodyweights were measured in 
BALB/c mice subchronically orally-exposed to chlorpyrifos (CP). Cumulative water and 
food consumption were normalized per mouse. Bodyweights are expressed as means ± SD 
(n = 6-8).  
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Figure 3-7. Subchronic chlorpyrifos does not alter gross duodenal architecture. 
No histological abnormalities were observed in the duodenal tissues (A). Mean duodenal 
villus length (B), villus width (C), lamina propria width (D), mucin+ cells/mm2 of villus 
(E), inner muscle width (F), and outer muscle (G) were quantified.  Scale bar = 200 µm. 
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Figure 3-8. Subchronic chlorpyrifos does not alter gross jejunal architecture. 
No histological abnormalities were observed in the jejunal tissues (A). Mean duodenal 
villus length (B), villus width (C), lamina propria width (D), mucin+ cells/mm2 of villus 
(E), inner muscle width (F), and outer muscle (G) were quantified.  Scale bar = 200 µm. 
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Figure 1-9. Subchronic chlorpyrifos does not alter gross colonic architecture. 
No notable histological abnormalities were observed in the colonic histology (A). Mean 
duodenal villus length (B), villus width (C), lamina propria width (D), mucin+ cells/mm2 
of villus (E), inner muscle width (F), and outer muscle (G) were quantified.  Scale bar = 
200 µm. 
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Table 3-1. Primers used for qPCR. 
 
 	
Gene Forward Primer Sequence Reverse Primer Sequence Efficiency R2 
B-actin GATGTATGAAGGCTTTGGTC TGTGCACTTTTATTGGTCTC 96.1 0.997 
Por CTCCAAGATCAGGTATGAATC GGAACGGATGCTTCTTATTC 92.4 0.979 
Fmo2 AAAGAGTTAACCTGTTTGGG GTACTGGTAGGAATTACAGGG 92.0 0.991 
Fmo3 CCTTTAAACAGAACACTCAGG GTGAACTCCTTTACATTAGGC 93.1 0.969 
Cyp1a2 CAATGACATCTTTGGAGCTG GATGAAGGCCTCTAGATATGG 109.99 0.940 
Cyp27b1 AGTGTTGAGATTGTACCCTG CGTATCTTGGGGAATTACATAG   
Cyp3a41b CCTGTCATTGAACAGTATGG GCACCTAACACATCTTTCATAG 89.01 0.999 
Cyp2b10 ACTCATAAGCTCATTCTCCAG ATGCGCAGAAGGTAAATATC 93.11 0.969 
Gclc CTATCTGCCCAATTGTTATGG ACAGGTAGCTATCTATCTATTGGTC 89.01 0.995 
Gss TATGGATGACCAGGAAGTTG CCCAGTTCTGTGAATTATACTG 123.64 0.948 
Gstn3 AGGTCACCTATGTGGATTTC GCTATCTTAGTAAACACAGGTC 138.16 0.947 
Abcb1a AGGACAAAAGAAGGAACTTG GATAAGGAGAAAAGCTGCTGCC 101.70 0.996 
Atf3 AAGACTGGAGCAAAATGATG GTCAGGTTAGCAAAATCCTC 104.59 0.998 
Egr1 CAGAGTCCTTTTCTGACATC GAGAAGCGGCCAGTATAG 110.82 0.992 
Gadd45a AGACCGAAAGGATGGACACG CCACGTTATCGGGGTCTACG 96.29 0.996 
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Chapter 4  
4 Enhancing innate immunity with beneficial microbes 
reduces pesticide-induced toxicity in Drosophila 
melanogaster: implications for colony collapse disorder. 
Trinder M, McDowell TW, Ali SN, Dube J, Leong HS, Sumarah MW, Reid G. 
4.1 Abstract 
Honeybees are experiencing massive population declines known as colony collapse 
disorder in North America, Europe, and Asia due to pathogens, neonicotinoid pesticides, 
and habitat loss. A link has been established between neonicotinoid-induced honeybee 
immunosuppression and subsequent increased risk of infections. Thus, we hypothesized 
that immunomodulation of honeybees with Lactobacillus plantarum ATCC 14917 (Lp 
39) would promote survival in response to imidacloprid (IMI, neonicotinoid) in 
Drosophila melanogaster model. Preliminary evidence for host-microbe interactions 
relevant to insect pro-survival in response to pesticides was demonstrated using 
Drosophila lacking the immune deficiency (IMD) pathway (RelE20). RelE20 Drosophila 
demonstrated significantly (p < 0.01) reduced larval eclosion and adult survival in 
response to both imidacloprid and organophosphate chlorpyrifos exposure. Furthermore, 
whole fly qPCR and IMD and Toll pathway reporter flies were used to demonstrate that 
Lp 39 oral supplementation modulates Drosophila immunity.  Interestingly, simultaneous 
treatment of adult wild type Canon-S Drosophila with 10 µM IMI and vehicle, Lp 39, or 
a L. plantarum strain isolated from Drosophila (Lpiso) demonstrated that Lp 39, but not 
Lpiso, improved early time point survival. Following 3 d prophylactic treatment with Lp 
39, there was significantly improved early (p < 0.05) and overall (p < 0.001) survival of 
Drosophila subsequently exposed to 10 µM IMI relative to vehicle controls. Further 
clarification that the Lp 39-mediated pro-survival effect was not dependent on a direct 
interaction between Lp 39 and IMI was confirmed by demonstrating that Lp 39 cannot 
bind or degrade IMI. Taken together, these findings provide a basis to test 
supplementation of honeybee colonies with Lp 39 for targeting multiple causes of colony 
collapse disorder associated with neonicotinoid pesticide exposure. 
114 
 
4.2 Introduction 
Apis melifera, commonly known as honeybees, are experiencing massive declines in 
North America, Europe, and Asia known as colony collapse disorder. This is problematic 
as honeybees are critical pollinators for roughly 35% of the global food crop (1), and 
thus, are largely responsible for the world’s food supply and important economically.  
Colony collapse disorder has been attributed to increased exposure of honeybees to a 
combination of pesticides (2) and pathogens (3) and increased loss of habitat (4, 5). 
Neonicotinoid insecticides are a class of pesticide that have been implicated as 
particularly toxic to bees (2, 6, 7). These compounds act as selective agonists for the 
nicotinic acetylcholine receptor, which induce bee growth abnormalities (6, 8), motor 
deficiencies (2, 9),  neurologic abnormalities (10), and/or death (2). The commonly used 
neonicotinoids, imidacloprid (IMI) and clothiadin, have also been shown to suppress 
immune function and consequently increase susceptibility to viral and fungal infections 
(11). Thus, the indirect damage to bee health may be more problematic than anticipated 
due to pesticides dysregulating the honeybee immune system and consequently making 
them more susceptible to infection. The current dilemma facing the agriculture industry is 
how to resolve the issue of preventing bee decline, while mitigating crop losses 
associated with pest infestations. One possible solution to this important economical 
problem is to fortify honeybee colonies with probiotic organisms (12).  
Probiotics are live microorganisms that confer beneficial effects to their hosts when 
consumed in adequate amounts. Lactobacilli spp. are Gram-positive commensal bacteria 
that have been shown to colonize honeybees (13, 14) and confer beneficial effects to their 
health and colony size (14-16). In addition, lactobacilli have been shown to reduce 
organophosphate pesticide contamination of fermented food products (17, 18) and 
regulate associated host xenobiotic detoxification pathways (19). We have shown that 
Lactobacillus species have the ability to sequester organophosphate pesticides from 
solution and mitigate the absorption and toxicity of these compounds in a Caco-2 
intestinal cell-line and Drosophila melanogaster, respectively (Trinder et al., submitted 
2016). However, the effect of lactobacilli on neonicotinoid pesticides is largely unknown.  
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Drosophila melanogaster (fruit fly) is a convenient insect organism to model the 
potential for lactobacilli to mitigate pesticide-induced toxicity in bees (11). Both fruit 
flies and honeybees have a core microbiota composed of Lactobacillus, with 
Lactobacillus plantarum being a major species in both hosts (12, 20, 21). This core  
microbiota is known to be sufficient for promoting normal fly development (22). As both 
species are insects, they are therefore profoundly affected by IMI in terms of toxicity and 
immunosuppressive effects (11, 23). Lactobacilli have been shown to induce positive 
effects on Drosophila (24) and honeybee (25) immune function. In particular, 
prophylactic lactobacilli supplementation has been shown to mitigate lethal Serratia 
marcescens and Pseudomonas aeruginosa infections in Drosophila (26). Despite, these 
observations the mechanisms of action of these microorganisms are underexplored.  
 The Drosophila protein Relish is a key signaling hub for coordinating host physiological 
responses to bacteria through the immune deficiency/nuclear factor kappa-light-chain-
enhancer of activated B cells (IMD/NF-KB) pathway. Relish is best characterized as a 
downstream transcription factor that elicits antimicrobial peptide immune responses to 
diaminopimelic acid (DAP)-type peptidoglycan activation of peptidoglycan recognition 
protein (PGRP)-LE in the midgut and PGRP-LC in the hindgut and foregut (27). 
Drosophila with IMD pathway loss of function phenotypes are significantly more 
susceptible to Gram-negative bacterial infections (28-30). The indigenous microbiota—
Lactobacillus and Acetobacter—are known to activate Relish in the gut, without 
downstream antimicrobial peptides due to negative regulation (24, 31). However, the 
implications of this interaction between intestinal Relish and the Drosophila indigenous 
microbiota is still poorly understood (31). These unanswered questions are interesting 
since Relish is critical for mediating Drosophila pro-survival responses to noxious 
stimuli (32). We hypothesized that L. plantarum supplementation would modulate 
Relish-dependent immune responses to mitigate IMI-induced Drosophila melanogaster 
mortality and toxicity.  
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4.3 Methods 
4.3.1 Bacterial strains and culture 
Lactobacillus plantarum subsp. plantarum (14917), Lp 39, was obtained from the 
American Type Collection Centre. An isolate of L. plantarum (Lpiso) was obtained from 
wild type Canton-S Drosophila.  Lactobacilli were inoculated from de Man, Rogosa and 
Sharpe (MRS) agar (BD, catalog number: 288130) or into MRS broth, then subcultured 
and incubated anaerobically overnight (18 h) at 37°C statically and anaerobically. 
4.3.2 Drosophila husbandry 
Wild type Canton-S (stock number: 1), RelE20 (stock number: 55714), y1 w*; P{UAS-
Dpt-cherry}C1 (Dpt-RFP, stock number: 55706), and P{Dipt2.2-lacZ}1, P{Drs-
GFP.JM804}1 , y1 w* (Drs-GFP, stock number: 55707) stocks were obtained from 
Bloomington Drosophila Stock Center at Indiana University. Drosophila were 
maintained using media containing 1.5% agar (w/v), 1.73% yeast (w/v), 7.3% cornmeal 
(w/v), 7.6% corn syrup (v/v), and 0.58% propionic acid (v/v) at 25°C with 12 h light/dark 
cycles. For experimental procedures media was supplemented with or without pesticide 
prior to agar solidification. Experiments with adult Drosophila used newly eclosed flies. 
All experiments were performed in polypropylene Drosophila vials (GEN32-121 and 
GEN49-102, Diamed Lab Supplies Inc., Mississauga, ON, Canada). 
Media was supplemented with 100 µL (109 CFU) of washed and concentrated lactobacilli 
or phosphate-buffered saline vehicle when experimentally appropriate and allowed to air 
dry before use. 
4.3.3 Chemicals 
IMI (catalog number: 37894) and chlorpyrifos (catalog number: 45395) were obtained 
from Sigma-Aldrich. Stock solutions were prepared at 10 mg/mL dimethyl sulfoxide 
(Sigma-Aldrich) and stored frozen at -80°C until usage.  
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4.3.4 Adult Drosophila survival assays 
Twenty to twenty-five newly eclosed Drosophila were transferred into standard vials 
containing media supplemented with vehicle or IMI and monitored daily for survival. 
Media was supplemented with 100 µL (109 CFU) of washed and concentrated Lp 39, 
Lpiso, or phosphate-buffered saline vehicle when experimentally appropriate and allowed 
to air dry before use. 
4.3.5 Eclosion assays 
Drosophila eggs were collected on grape agar plates. Ten 1st-instar larvae were 
transferred to Drosophila media, incubated at aforementioned conditions, and monitored 
daily for up to 16 d for eclosion.  
4.3.6 Intravital confocal microscopy 
Dpt-RFP or Drs-GFP Drosophila were exposed to cotton gauze soaked in 109 CFU/mL 
Lp 39 or 5% sucrose (w/v) vehicle for 15 or 24 h, respectively. Wild type Canton-S fed 
5% sucrose were used as negative controls. Flies were anesthetized with FlyNap 
(Carolina Biological Supply Company), immobilized, and imaged using tri-channel laser 
resonance confocal microscopy (Nikon Inc., Tokyo, Japan). Dpt-RFP Drosophila guts 
were also dissected and counterstained with 162 µM Hoechst 33342, trihydrochloride, 
tetrahydrate (Molecular Probes, catalog number: H3570).  Using 4x and 20x objective 
lenses, the 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI, 408 nm) channel was 
utilized to provide background contrast, the Alexa594 (594 nm) channel was used to 
visualize the RFP expression in dissected guts and the FITC (488 nm) channel was used 
to visualize GFP expression in the whole fly. Multichannel and z-stack images were 
taken using the NIS-Elements Advanced software (Nikon Inc., Tokyo, Japan). 
4.3.7 RNA extraction, reverse transcription, and qPCR 
Canton-S Drosophila were exposed to cotton gauze soaked in 109 CFU/mL Lp 39 or 5% 
sucrose (w/v) vehicle for 24 h. Whole flies were flash frozen and stored at -80°C until 
RNA extraction. Twenty flies were homogenized in 1 mL of TRIzol (Ambion, catalog 
number: 15596018) using a motorized pestle. After phase separation with chloroform 
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according to the manufacturer’s protocol, the aqueous phase was combined with equal 
volume of 100% ethanol. RNA purification was continued using a PureLink RNA Mini 
Kit (Ambion, catalog number: 12183025) with on-column treatment of PureLink 
DNase treatment (Ambion, catalog number: 12185010). RNA quantity and purity was 
assessed with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific).  RNA was 
stored at -80°C until reverse transcription. 
cDNA was prepared from 200-2000 ng of purified total RNA using a High-Capacity 
cDNA Reverse Transcription Kit (Applied Biosystems, catalog number: 4368813). qPCR 
was performed with a 7900HT Sequence Detection System (Applied Biosystems) in 20 
µL reactions using Power SYBR Green Master Mix (Applied Biosystems, catalog 
number: 4368702) with 200 µM of appropriate forward and reverse primers. Primers used 
for qPCR analysis can be found in Supplementary Table 4-1. qPCR results were analyzed 
using SDS RQ 6.3 manager software (Applied Biosystems) and relative gene expression 
was calculated using the 2−ΔΔct method.  
4.3.8 Pesticide binding and metabolism assay. 
Overnight bacterial subcultures were pelleted at 5000 g. Pellets were washed and re-
suspended in 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 
6.8). Bacterial-buffer or buffer-alone solutions were incubated with IMI protected from 
light at 37°C for 24 h (unless otherwise stated) with gentle shaking. Cultures were 
pelleted and supernatant collected then analyzed for IMI levels using liquid-
chromatography mass spectrometry. 
An Agilent 1290 Infinity high performance-liquid chromatography (HPLC) coupled to a 
Q-Exactive Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, USA) with 
a HESI (heated electrospray ionization) source. Two µL of each sample was injected into 
a ZORBAX Eclipse plus C18 2.1 x 50mm x 1.6 µm column.  Mobile phase (A) consisted 
of 0.1% formic acid in water and mobile phase (B) consisted of 0.1% formic acid in 
acetonitrile.  The initial composition of 0% (B) was held constant for 0.5mins and 
increased to 100% over 3.0 minutes. Mobile phase B was then held at 100% for 1.5 
minutes and returned to 0% over 30 seconds, re-equilibrated at 0% (B) for 1 minute for a 
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total run time of 6.5 min.  
The HESI source was operated under the following conditions: nitrogen flow of 20 and 9 
arbitrary units for the sheath and auxiliary gas respectively, probe temperature and 
capillary temperature of 450 °C and 400 °C respectively and spray voltage of 3.9 
kV.  The S-Lens was set to 65.  A full MS with a top 10 data dependent (ddMS2) was 
conducted at a full MS scan between the ranges of 160-1500 m/z in positive mode at 
35,000 resolution (AGC target and maximum injection time were 3e6 and 120 ms 
respectively) and MS/MS at 17,500 resolution, normalized collision energy set to 27 
(AGC target and maximum injection time of 1 x 105 and 60ms, respectively).  
4.3.9 Pesticide tolerance assay. 
Overnight broth cultures (stationary phase) were subcultured (1:100 dilution) into 96 well 
plates (Falcon, catalog number: 351177) containing MRS broth with or without the 
addition of IMI or vehicle (DMSO).  Plates were incubated at 37°C and read every 30 
min for 24 h at a wavelength of 600 nm using a Labsystems Multiskan Ascent microplate 
reader.  
4.3.10 Statistical analyses 
All statistical analyses were performed in GraphPad Prism 6 using unpaired t-tests or 
Mann-Whitney tests, one-way analysis of variance with Tukey’s multiple comparison 
tests, or two-way analysis of variance tests with Tukey’s multiple comparison tests as 
appropriate. Alternatively, Mantel-Cox and Gehan-Breslow-Wilcoxon tests were used for 
Drosophila survival analyses. 
4.4 Results 
4.4.1 Relish is necessary for mitigating pesticide-induced toxicity 
in Drosophila 
Relish has been shown to be an important for promoting Drosophila survival in response 
to ultraviolet light-induced stress (32). Similarly, to determine the importance of Relish 
for mediating Drosophila pesticide tolerance, the survivability and development of 
Relish-knockout (RelE20) flies were compared to age-matched wild type Canton-S flies. 
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Adult wild type Canton-S Drosophila demonstrated significantly prolonged overall (p < 
0.0001) and early (p < 0.0001) time point survival relative to RelE20 mutants when 
lethally exposed to 100 µM IMI or 10 µM CP (Figure 4-1A). Notably, median survival of 
RelE20 and wild type Canton-S Drosophila exposed to 100 µM IMI were 1 and 7 d, 
respectively. This corresponded to all RelE20 Drosophila succumbing to mortality at 4 d 
post-100 µM IMI exposure; in contrast, 17.526% of wild type Canton-S Drosophila 
remained alive at the 12 d experimental endpoint following 100 µM IMI exposure. Adult 
wild type Canton-S and RelE20 mortality on vehicle media was negligible (data not 
shown). Furthermore, eclosion assays confirmed that RelE20 larvae were significantly 
more (p < 0.01) sensitive to imidacloprid- (10 µM) and chlorpyrifos-induced (1 µM) 
toxicity than Canton-S wild type controls (Figure 4-1B). Together these results suggest 
that Relish is necessary for promoting Drosophila survival in response to toxic pesticide 
insult.  
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Figure 4-1. Relish is necessary for mitigating pesticide-induced toxicity in 
Drosophila. 
(A) 1st-instar wild type Canon-S or Rel[E20] larvae were monitored for eventual eclosion 
following incubation on imidacloprid (IMI), chlorpyrifos (CP), or vehicle. Data are 
expressed as means ± SD from at least 3 independent experiments. (B) Survival curves of 
newly eclosed wild type Canton-S or Rel[E20] Drosophila exposed to media containing 
100 µM IMI or 10 µM CP. Data are displayed from at least 3 independent experiments. 
** p < 0.01, *** p < 0.001, **** p  < 0.0001. 
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4.4.2 Lactobacillus plantarum supplementation alters Drosophila 
immune function through the IMD/Relish, and potentially Toll 
pathways. 
Since the Drosophila gastrointestinal microbiota is comprised largely of lactobacilli, 
which have been shown to induce IMD/Relish signaling (24), it was predicted that Lp 39 
supplementation would also activate the IMD/Relish and/or Toll pathways. This 
hypothesis was assessed by determining the activation of Dpt and Drs, which encode 
downstream antimicrobial effectors of the IMD/Relish and Toll pathways, respectively. 
Adult Dpt-RFP Drosophila acutely orally exposed (15 h) to Lp 39 demonstrated 
increased expression of the IMD/Relish downstream antimicrobial peptide gene, 
Diptericin (Dpt), in the midgut compared to sucrose-treated controls (Figure 4-2A). 
Interestingly, whole fly gene expression of Canton-S Drosophila, determined by qPCR, 
demonstrated that Dpt was significantly repressed (p < 0.05) following 24 h of oral Lp 39 
supplementation (Figure 4-2B). However, these differences could potentially be 
explained by conflicting time points of analysis following Lp 39 exposure. This is 
supported by observations noting that the activation of Drosophila antimicrobial 
responses has been shown to activate and decline rapidly following microbial exposures 
(28, 29). Alternatively, newly eclosed Drs-GFP Drosophila appeared to show increased 
expression of the Toll downstream response antimicrobial peptide gene, Drosomycin 
(Drs), following 24 h of oral Lp 39 supplementation (Figure 4-3A). This finding was 
corroborated with an increase in Drs expression, as determined by qPCR of extracted 
RNA from whole flies following 24 h of oral Lp 39 supplementation (Figure 4-3B). Thus, 
Lp 39 oral supplementation induces innate immune changes in Drosophila that may have 
implications to promoting Drosophila survival and/or resilience to pathogen, toxin, or 
stress exposures. 
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Figure 4-2. Drosophila show altered diptericin expression in response to Lp 39 oral 
supplementation. 
(A) Newly eclosed Dpt-RFP Drosophila and negative control wild type Canton-S were 
orally supplemented with Lp 39 or vehicle for 15 h. Drosophila midguts were dissected, 
nuclear counterstained with 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) and 
viewed by confocal microscopy. Scale bar = 20 µm (B) Diptericin (Dpt) gene expression 
of newly eclosed whole wild type Canton-S Drosophila was determined following 24 h 
oral supplementation with Lp 39 or vehicle (n = 4 independent experiments). Data are 
expressed as means ± SEM. * p < 0.05.  
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Figure 4-3. Drosophila may show enhanced drosomycin secretion in response to Lp 
39 oral supplementation. 
(A) Newly eclosed Drs-GFP Drosophila and negative control wild type Canton-S were 
orally supplemented with Lp 39 or vehicle for 24 h. Drosophila were anesthetized and 
viewed by confocal microscopy for intravital imaging. GFP signal represents secreted 
drosomycin. Scale bar = 500 µm. (B) Drosomycin (Drs) gene expression of newly 
eclosed whole wild type Canton-S Drosophila were determined following 24 h oral 
supplementation with Lp 39 or vehicle (n = 4 independent experiments). Data are 
expressed as means ± SEM. 
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4.4.3 Lp 39 promotes point survival of Drosophila exposed to 
imidacloprid 
Given that the IMD/Relish pathway is critical for promoting Drosophila survival 
following lethal pesticide challenge and that Lp 39 appears to modulate the IMD/Relish 
pathway, it was reasoned that Lp 39 could confer resilience to Drosophila challenged by 
pesticide. Adult Canon-S Drosophila were found to suffer acute IMI-induced mortality at 
feed concentrations of 10 µM, but not 1 µM (Figure 4-4A). Therefore, we tested the 
hypothesis that Drosophila exposed to Lp 39 would promote survival with simultaneous 
10 µM IMI exposure. This hypothesis was also compared to supplementation with a L. 
plantarum (Lpiso) strain isolated from our wild type Canton-S colony. Canton-S 
Drosophila treated with vehicle had negligible mortality by the experimental endpoint 
(data not show). Adult Canton-S Drosophila treated with Lp 39 were less prone (p = 
0.0580) to early time point IMI-induced mortality than the non-supplemented 
counterparts (Figure 4-4B). However, Lp 39 did not demonstrate appreciable protection 
against IMI-induced mortality long-term (p = 0.9961). Median survival of flies treated 
with vehicle, Lp 39, or Lpiso during 10 µM IMI challenge were 10, 8, and 7 d 
respectively. Interestingly, Drosophila treated with Lpiso were significantly more prone to 
early (p <  0.05) and late (p <  0.01) time point IMI-induced mortality compared to Lp 39 
and non-supplemented groups, respectively (Figure 4-4B). These results suggest that 
prophylactic priming of Drosophila with Lp 39 may be required for the observation of 
long-term survival benefits in IMI-challenged flies. Furthermore, the strain of 
Lactobacillus plantarum administered to Drosophila appears to confer different 
outcomes to IMI-challenged flies. This observation supports the notion of strain-
dependent effects of supplementing organisms with beneficial microbes. 
It was predicted that prophylactic treatment of Drosophila with Lp 39 prior to IMI would 
prime host tolerance to IMI-induced toxicity. Hence, aforementioned experiments were 
adapted to provide newly eclosed adult Drosophila with 3 d prophylactic exposure to Lp 
39 or vehicle prior to 10 µM IMI challenge. Adult Canton-S Drosophila that were 
pretreated with Lp 39 for 3 d were significantly more tolerant to early (p < 0.05) and late 
(p < 0.001) IMI-induced mortality relative to vehicle treated controls (Figure 4-4C). 
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Median survival of Drosophila pretreated with vehicle or Lp 39 were 10 and 11 d, 
respectively. Moreover, Drosophila pretreated with Lp 39 had notably greater long term 
survival (14.811% alive at d 22) compared to vehicle controls (2.139 % at d 22) 
challenged with 10 µM IMI. These experimental results are interesting given that 
Drosophila were provided only a single Lp 39 inoculum in the feed for 3 d prior to 
pesticide exposure. Thus, prophylactic exposure to beneficial microbes appears to prime 
Drosophila to cope with toxic-insult. 
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Figure 4-4. Lp 39 promotes point survival of Drosophila exposed to imidacloprid. 
(A) Survival curves of newly eclosed wild type Canton-S Drosophila were exposed to 
media containing 1 or 10 µM imidacloprid (IMI) or vehicle control. (B) Survival curves 
of newly eclosed wild type Canton-S Drosophila were exposed to media containing 10 
µM CP with or without simultaneous supplementation of live Lp 39 or Lpiso.  (C) 
Survival curves of newly eclosed Drosophila melanogaster exposed to Lp 39 or vehicle 
for 3 d, following subsequent exposure to media containing 10 µM IMI. Data are 
displayed from at least 3 independent experiments.   
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4.4.4 Lp 39 can tolerate, but not bind or metabolize, imidacloprid 
In order to provide stronger evidence that prophylactic Lp 39 supplementation benefited 
Drosophila subsequently challenged with IMI by a microbe-host interaction rather than 
microbe-toxin interaction, the interactions between Lp 39 and IMI were determined. It 
was first assessed if IMI had notable toxic effects on Lp 39, which could alter Lp 39 
behavior in culture or infer the potential of IMI to be toxic to members of the Drosophila 
gut microbiota. However, Lp 39 was shown to grow unimpaired at high concentrations of 
IMI (1 mg/mL ≈ 3911 µM, Figure 4-5A). Alternatively, the ability of Lp 39 was also 
tested for its ability to promote the degradation of IMI in vitro. However, several strains 
of lactobacilli, including Lp 39, failed to demonstrate any notable metabolism or binding 
of imidacloprid (0.1 mg/mL, ≈ 391.1 µM) following 24 h co-incubations (Figure 4-5B). 
These findings suggest that beneficial effects of Lp 39-treatment on Drosophila 
survivability to IMI challenge are not a consequence of direct interactions between Lp 39 
and IMI. 
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Figure 4-5. Lp 39 can tolerate, but not bind or metabolize, imidacloprid. 
(A) Percent imidacloprid (IMI) was determined in stationary phase live bacterial cultures 
relative to pesticide-only controls following 24 h co-incubations in 50 mM HEPES. Data 
are depicted as means ± SD of 2 independent experiments. (B) Growth curves of Lp 39 in 
MRS supplemented with vehicle or imidacloprid (IMI). Data are depicted as means ± 
SEM of 3 independent experiments with triplicate technical replicates.  
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4.5 Discussion  
This study demonstrated that oral Lp 39 supplementation improved survival of 
Drosophila lethally exposed to IMI. There has been considerable investigation into the 
ability of beneficial microbes to sequester environmental toxins from food products. 
Lactobacillus species have been shown to degrade several organophosphate pesticides 
from fermented food products (17, 18, 34). However, the bioremediation of neonicotinoid 
pesticides is less well-understood. In our study, out of the few strains tested, we did not 
identify any Lactobacillus species capable of IMI degradation. Other studies have 
observed bacteria such as Pseudoxanthomonas (35), Ochrobactrum (36), Mycobacterium 
(37), Stenotrophomonas (38),  Ensifer (39), and Bacillus (40) with IMI-degrading 
potential. However, the relevance of these organisms to in vivo bioremediation 
applications is unlikely given the observations of notable IMI degradation only after 
several days following experimentation. Nevertheless, these studies provide promise for 
engineering gain-of-function beneficial microbes once the genetic details of IMI 
degradation are better defined. The current benefits of lactobacilli supplementation on 
insects challenged with neonicotinoid pesticides may largely be a result of immune 
modulation.  
Similar to other studies evaluating Drosophila larvae response to ultraviolet light-induced 
damage (32), this study has shown that the innate immune IMD pathway is necessary for 
Drosophila pro-survival in response to pesticides as both larvae and adults. Although 
complete understanding of this complex molecular signaling cascade is unclear, negative 
interactions between NF-KB/Relish and insulin/insulin growth factor signaling (ISS) have 
been shown to be crucial for growth homeostasis in response to DNA damage (32). The 
current working hypothesis suggests that systemic Janus tyrosine kinase/signal transducer 
and activator of transcription (JAK/STAT) pathway activation lead to a hemocyte-
dependent repression of ISS in response to damage (32). Recovery of IIS requires Foxo-
dependent NF-KB/Relish in the fat body to normalize ISS and maintain organismal 
homeostasis.  
There is conflicting evidence for the duration of exposure and dose required for IMI-
induced genotoxicity (41, 42), but it is also possible that pesticide-induced tissue damage 
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itself requires the IMD pathway for maintenance of organismal physiology to sustain 
survival (43). These claims are supported by observations of damaged cells releasing 
JAK/STAT-activating cytokines Unpaired 1–3 (Upd 1–3, 44-46).  
Neonicotinoid pesticides have also been shown to downregulate NF-KB insect immune 
responses at sub-lethal concentrations due to upregulation of the NF-KB negative 
regulator gene CG1399 present in Drosophila (11). Under normal physiological 
conditions, NF-KB negative regulator genes require downregulation to initiate immune 
responses following infection (47). These observations are supported by increased fungal 
Nosema apis colonization (48) and pathogenicity (49), and deformed wing virus 
replication (11) in honeybees exposed to neonicotinoid pesticides. Given the importance 
of the innate immune system for regulating the insect intestinal microbiome (24, 31), the 
effect of neonicotinoids on microbiota composition remains to be elucidated. 
Imidacloprid has also been shown to alter microbial ecosystems in soil (50, 51). Thus, the 
potential extrapolation of interplay between neonicotinoid pesticides and the gut 
microbiome requires further study given the gut ecosystem importance for regulating 
numerous aspects of insect physiology such as growth (22), lifespan (52), and mating 
behavior (53). 
Since acute IMD pathway activation can prime Drosophila to mitigate infections by 
pathogens (26, 54), we reasoned that targeting this pathway with beneficial 
microorganisms could also promote survival and rescue immune deficiencies experienced 
in Drosophila or honeybees during neonicotinoid pesticide challenge. The honeybee has 
several homologues with high amino acid sequence similarity to the Drosophila Relish 
protein such as the predicted nuclear factor NFKB p110 subunit isoform X1 
(XP_006562282.1), dorsal (NP_001011577.1), and Relish itself (ACT66913.1). These 
observations combined with the highly conserved nature of innate immunity suggest that 
translation of these findings will be amendable for future studies in honeybees (55). 
Moreover, the use of lactobacilli as honeybee probiotics has been shown to enhance 
immune responses (25). These findings are analogous to the observations of IMD 
pathway modulation in Drosophila supplemented with Lp 39 seen in this study. Future 
work is attempting to definitively demonstrate that the observations of Lp 39-mediated 
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extension of Drosophila survival during IMI exposure is dependent on IMD/Relish 
pathway modulation. The extension of these findings to honeybees is promising given 
that colony supplementation with lactobacilli is affordable, feasible, and has already been 
shown to benefit honeybee colony growth (56), microbiota composition (16, 57), and 
antimicrobial defense (12, 21, 58). 
In summary, this study demonstrated the importance of: 1) the IMD immune pathway for 
promoting Drosophila pro-survival in response to neonicotinoid pesticide challenge, 2) 
IMD/Relish pathway modulation by oral exposure to exogenous beneficial microbes, and 
3) Lp 39-mediated protection of Drosophila lethally-exposed to IMI. These results 
suggest supplementation of honeybee colonies with lactobacilli has the potential to 
mitigate both direct IMI-induced toxicity and IMI-immunosuppressive effects. These 
findings support the simple and economically affordable supplementation of honeybee 
colonies with lactobacilli to mitigate multiple causes of colony collapse disorder.  
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4.7 Supplementary 
Table 4-1. Primers used for qPCR. 				
Gene Forward Primer Sequence Reverse Primer Sequence 
RpL32 GTTAGTCCGTGCGCTGTTC CATCTTGAAGAGGAATCGATCCGAA 
Dpt CCACTGGCATATGCTCCCAAT CAAGGTGCTGGGCATACGAT 
Drs TACTTGTTCGCCCTCTTCGC CACCAGCACTTCAGACTGGG 
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Chapter 5  
5 General discussion 
5.1 Future directions 
5.1.1 Better characterize lactobacilli-organophosphate binding 
interactions. 
Experiments demonstrated that stationary phase cultures (109 CFU/mL) of Lactobacillus 
rhamnosus GG (LGG) and GR-1 (LGR-1) could passively sequester high concentrations 
of organophosphate pesticide (100 ppm parathion or chlorpyrifos) from 50 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) solution after 24 h. However, 
the dose-response relationship, kinetic, potential buffer effect, and mechanism of action 
still remain unknown.  
This will be evaluated for concentration of pesticide and bacteria. Live and heat-killed 
strains of 109 CFU/mL LGR-1 and LGG will be incubated with 100, 50, 10, or 1 µM of 
parathion or chlorpyrifos (CP) for 24 h in 50 mM HEPES. Alternatively, live and heat-
killed strains of 109, 108, 107, and 106 CFU/mL LGR-1 and LGG will be incubated with 
100 µM of parathion or CP for 24 h in 50 mM HEPES. Serial supernatant samples will be 
collected at 0.25, 3, and 24 h. Supernatant samples will be analyzed by high performance 
liquid chromatography with ultraviolet detection for comparison of pesticide levels 
relative to untreated samples as previously described in Chapter 2.  
Interestingly, in Caco-2 Transwell experiments, the amount of organophosphate pesticide 
sequestration observed by LGR-1 and LGG was much less than anticipated based on 
previous binding experiments (data not shown). One major difference between 
experiments was the usage of 50 mM HEPES and Hank’s balanced salt solution (HBSS) 
for the binding and Caco-2 Transwell experiments, respectively. It is possible that 
different buffers alter the proposed binding phenotype initially observed. This 
phenomenon will be evaluated by repeating the aforementioned experiments using 1x 
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HBSS as the solvent (instead of 50 mM HEPES). These experiments will hopefully 
elucidate if solvent conditions play an important role in mediating lactobacilli-
organophosphate binding. 
Based on initial experiments, the ability of bacteria to sequester organophosphate 
pesticides from solution appears to be relatively generic. CP levels in the homogenized 
and methanol-treated LGR-1 and LGG pellets suggests that these similar strains may 
differ in either affinity or binding potential. There are some unique differences to LGR-1 
predicted outer-membrane proteins and an exopolysaccharide biosynthesis cluster (Dr. 
Jean Macklaim, unpublished poster). Thus, we plan to isolate exopolysaccharide from 
LGR-1 and LGG to evaluate their organophosphate binding potential. This experiment 
will attempt to decipher the mechanism of action for LGG and LGR-1 interactions with 
organophosphate pesticides.   
5.1.2 Enhance the ability of Lactobacillus rhamnosus GG and GR-
1 to metabolize organophosphate pesticides. 
I have designed a gene construct that contains the experimentally confirmed parathion 
hydrolase gene from Brevundimonas diminuta under the promotion and termination of 
the lactate dehydrogenase gene found in LGG. Preliminary experiments attempted to 
insert this construct into LGG and/or LGR-1 using the Escherichia coli-Lactobacillus 
shuttle pLAB1301 vector. Sequencing and qPCR results suggest this gene failed to be 
incorporated into the organism despite conferred erythromycin resistance (selectable 
marker). Swapping gene promoters from lactate dehydrogenase to dlt has been advised 
as an additional consideration for optimal expression. This strategy is feasible given that 
the gene construct was designed and synthesized for alteration of promoter, terminator, or 
gene of interest by restriction enzyme digestion. Reattempting this transformation would 
allow for assessment of potentially improved LGG or LGR-1-mediated bioremediation 
potential given that these strains were shown to bind but not degrade CP or parathion in 
Chapter 2. 
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5.1.3 Animal studies to investigate the functional effect of L. 
rhamnosus GR-1 on pesticide/drug/toxin metabolism.  
Our work has shown that acute supplementation of BALB/c mice with LGR-1 can alter 
host defensome gene expression in the small intestine, liver, and kidney. Although 
previous work has used germ-free animals to show that the microbiota is critical to host 
xenobiotic metabolism (1-5), few studies have characterized the various effects of 
individual species or strains in a non-sterile host (1, 6). These latter findings have 
important translational implications to human pharmacology and toxicology. We have 
shown that hepatic P450 oxidoreductase (Por), flavin containing monooxygenase 1 
(Fmo1), and Fmo2 are significantly upregulated in mice treated with LGR-1. Por 
catalyzes the transfer of electrons to most cytochrome P450 (Cyp) enzymes, and 
consequently is important to xenobiotic (7, 8) and toxin (9) metabolism in vivo. Thus, we 
hypothesize that supplementing the gastrointestinal microbiota with beneficial 
Lactobacillus can prevent the systemic absorption of orally acquired toxic compounds 
such as the organophosphate pesticide chlorpyrifos through the modulation of xenobiotic 
metabolism. We plan to further investigate this by mechanistically deciphering the effects 
of LGR-1 supplementation on the functional activity of mouse CYP homologues relevant 
to human chlorpyrifos metabolism (CYP2C9, CYP2C19, CYP2B6, and CYP3A4). In 
particular, the activities of CYP2C19 and CYP2B6 have been implicated in chlorpyrifos 
detoxification and toxicity, respectfully. 
Female BALB/c mice, aged 5-6 weeks, obtained from Charles River, were randomly 
assigned into saline or LGR-1 treatment conditions. Mice were orally-gavaged vehicle 
(n=9) 109 CFU of L. rhamnosus GR-1 (n=9) daily for 3 d prior to sacrifice. Livers, 
kidneys, duodenum, and jejunum were flash frozen and stored at -80°C for downstream 
protein analysis. Blood was collected, separated into plasma and cellular components, 
aliquoted separately, and stored at -80°C until required. Fecal pellets and small intestinal 
swabs were flash frozen at sacrifice. Metabolomic analysis of these samples using liquid 
chromatography-mass spectrometry (LC-MS) will help mechanistically explain the 
changes in host xenobiotic gene expression we observed previously.  
145 
 
Livers will be homogenized and ultracentrifuged to isolate microsomes for downstream 
Cyp450 activity assays. Chlorpyrifos will be incubated with hepatic microsomes and 
plasma from each experimental group. Selective activity of microsomal activity of 
Cyp3a11 (human Cyp3A4 homolog), Cyp2b10 (human CYP2B6 homolog), and Cyp2c29 
(human CYP2C19) will be evaluated between experimental groups in parallel to 
chlorpyrifos by co-incubating isolated microsomes with probe substrates midazolam, 
bupropion, and tolbutamide, respectively. Similarly, plasma esterase activity will be 
assessed by co-incubating isolated plasma with probe substrates propantheline and 
propoxycaine. Test compounds (1 µM for microsomes, 5 µM for plasma) will be co-
incubated with isolated microsomes (0.5 mg/mL) or plasma for 0, 15, 30, 45, and 60 min 
in triplicate. Samples will be prepared for parent and metabolite compound analysis by 
liquid chromatography-mass spectrometry. The formation of metabolites will be 
determined by comparing the peak area of the metabolite compound at each time point to 
time zero. Each compounds half-life for a given treatment will be estimated from the 
logarithmic curve of parent compound remaining vs. time given the assumption of first 
order kinetics. The apparent intrinsic clearance will be calculated from the half-life value 
for assays with microsomes or plasma. 
Forty-eight female BALB/c mice, aged 5-6 weeks, will be obtained from Charles Rivers. 
Mice will be housed in 4 separate cages (12 mice/cage). Mice from each cage will be 
used to assess a single pharmacological parameter described below. Mice in each cage 
will be randomly selected for vehicle or experimental treatment at a ratio of 1:1. Mice 
will be orally-gavaged vehicle or 109 CFU of GR-1 daily for 3 d prior to sacrifice. Plasma 
parent concentrations, metabolite concentrations, and pharmacokinetic parameters will be 
determined as the mean from 3 animals (10). All animals will be food-deprived for 16 h 
prior to experimentation. Mice will be administered an oral or intravenous (tail vein 
injection) dose of midazolam (Cyp3a11 probe), bupropion (Cyp2b10 probe), or 
tolbutamide (Cyp2c29 probe). Serial blood samples (20-30 µL) will be collected at 5, 30, 
60, 180, and 360 min. Animal work will be performed by an experienced animal 
technician to ensure experimental accuracy and animal safety. Blood will centrifuged to 
separate plasma and hematocrit. Samples will be stored at -80°C until analysis by LC-
MS. Livers, kidneys, duodenum, and jejunum will be flash frozen and stored at -80°C for 
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downstream protein analysis. Together these experiments will enable a better 
understanding of the mechanisms and functional consequences of LGR-1-mediated 
modulation of host xenbiotic metabolism gene expression. These findings could provide 
important insight into how fermented food products consumption could influence the 
clinical variation observed in the efficacy and toxicity of commonly used medications.  
5.1.4 Evaluation of Lactobacillus rhamnosus GR-1-induced 
changes to P-glycoprotein activity relevant to intestinal 
chlorpyrifos absorption 
We have shown that duodenal Abcb1a/ P-glycoprotein expression is altered in mice 
treated with LGR-1. We will further investigate this result by evaluating intestinal P-
glycoprotein protein levels and protein localization in mice from the aforementioned 
experiments by western blotting and immunofluorescence, respectively. To 
mechanistically determine if GR-1 can affect P-glycoprotein function, we will perform 
bidirectional P-glycoprotein transporter assays on differentiated Caco-2 cell monolayers 
in 12-well, 0.4 µm Corning Transwell Inserts. Cells will be pretreated for 24 h with LGR-
1 lysates or vehicle. Transport assays will be performed in HBSS / HEPES solutions 
containing 10 µM digoxin as a P-glycoprotein probe substrate. Sampling will be taken at 
20 µL and 100 µL volumes from the donor and receiving sides, respectively. Donor 
sampling will be taken at 0 and 80 min. Receiver sampling will be taken at 20, 40, 60, 
and 80 min.  Integrity of Caco-2 monolayers will be confirmed following 
experimentation by lucifer yellow rejection. Collected samples will be analyzed for 
digoxin using LC-MS.  Two independent experiments with treatments completed 
containing technical replicates in triplicate will be performed. Digoxin permeability 
coefficient and efflux ratios will be calculated for experimental conditions as described 
(11). Follow-up experiments will use the outlined Caco-2 experimental workflow to 
evaluate chlorpyrifos absorption with or without the use of the P-glycoprotein chemical 
inhibitor verapamil. The latter experiment could help elucidate if GR-1 can prevent CP 
absorption by enhancing intestinal P-glycoprotein activity. 
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5.1.5 Further characterization of Relish and its role in toxicology 
and potential for targeting by microbes 
We have shown that the protein, Relish, is necessary for promoting Drosophila survival 
in response to pesticide (organophosphate or neonicotinoid) challenge (Chapter 4). Relish 
is most known for its role in mediating antimicrobial peptide responses to Gram-negative 
bacteria, but has been shown to be important for promoting survival in response to 
noxious stimuli (12, 13). This is particularly interesting given that this pathway is subject 
to regulation by indigenous microbiota species, such as Lactobacillus, present in the gut. 
Together these observations suggest that modulation of this pathway with beneficial 
microbes may promote survival and immune function of important insect species, such as 
honeybees, that are orally-challenged by pesticides. Future experiments could test the 
sufficiency of Relish for promoting Drosophila survival using both gut localized and 
constitutive Relish overexpression with the UAS/GAL4 system (14). The work would be 
complemented with better characterization of how oral supplementation of Drosophila 
with Lactobacillus species modulate the intestinal IMD pathway and its relevance to 
pesticide-induced immune susceptibility. This hypothesis of host-microbe interactions 
promoting survival following pesticide challenge would be further evaluated using 
Drosophila that have been derived germ-free or subjected to life-long antibiotic exposure 
(15). Other future experiments could combine IMD pathway reporter Drosophila strains, 
gene expression analysis, and infection models.  Hopefully, the resultant data would 
demonstrate the importance of how directly targeting the IMD pathway with beneficial 
microbes can mitigate direct and immunosuppressive toxicity of neonicotinoid pesticides 
to insects. 
5.2 Conclusions and implications 
Despite the support for lactobacilli being a potential pesticide detoxification mediator in 
vitro and ex vivo in food, it was only recently that our lab first demonstrated that chronic 
consumption of yogurt-supplemented with Lactobacillus rhamnosus GR-1 was able to 
reduce systemic bioaccumulation of mercury and arsenic in Tanzanian pregnant women 
and children (16). People living around Lake Victoria (Tanzania, Uganda, Kenya) are 
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exposed to heavy metals, pesticides, and other environmental toxins, particularly through 
ingestion of fish and water. This issue is also relevant to North Americans, as people 
living along Lake Erie and Lake Ontario have the potential to be exposed to comparable 
levels (17, 18). However, North Americans are warned not to consume toxin-laden fish, 
and have the ability to cope with this resource shortage by accessing alternative foods. In 
Tanzania and Uganda where lake fish are part of their staple, affordable diet, this is not 
an option. Thus, the potential to consume locally produced nutritious yogurt, containing 
bacteria that can sequester toxins, has great appeal to provide major health and longevity 
benefits to the residents of Lake Victoria.  Efforts are now underway to provide people 
with the opportunity to make such probiotic yogurt containing LGR-1 or LGG (generic 
strain Yoba).  
Although the chemical structures of heavy metals and pesticides differ notably, the 
present study’s findings provide optimism that lactobacilli may have the ability to act as 
cost-effective broad-spectrum detoxification. Our lab has proposed clinical field studies 
to be conducted in Africa using our established Western Heads East and the new 
International Development Research Centre program. These projects will allow for 
testing the clinical efficacy of LGR-1 and Yoba in preventing pesticide exposure in 
humans at high risk. The contents of this thesis have provided a rationale for the anti-
pesticide effects.  
The ability of probiotic lactobacilli to prevent the systemic absorption of certain 
pesticides could also be valuable to the agriculture industry. The recent concerns over 
severe toxicity of neonicotinoid pesticides to honeybees, critically important pollinators, 
will put pressure on the industry to find other means to kill pests without also killing 
bees. The colonization of insects by symbiotic bacterial species can confer pesticide 
resistance (19), and specifically, the ability of lactobacilli to modulate health benefits to 
honeybee colonies has already been shown to be relevant for gastrointestinal pathogen 
control (20). Since beekeepers already use ‘pollen patties’ to provide extra nutritional 
nourishment to bee colonies, there is a possibility that supplementing these patties with 
probiotic lactobacilli could mitigate neonicotinoid-induced “colony collapse disorder”.  
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Probiotics already form an important component of the aquaculture industry to promote 
the growth and reproduction of fish (21-23). Highly adhesive strains of probiotic 
lactobacilli have been identified for colonization of the fish intestine and improving 
defenses (24). By protecting fish against pesticides that have leached into soils and 
subsequently returned to the water supply as a result of runoff, the associated toxicity of 
pesticide bioaccumulation imposed on humans, via the consumption of these 
contaminated animals, may also be mitigated.  
The consequences of environmental pesticide pollution due to widespread usage in 
agriculture and soil leaching are starting to become a major societal concern. Although 
some of the long-term effects of pesticide exposure to humans and wildlife remain 
unknown, logic suggests these chemicals are not aligned with ecosystem health. Most 
research focusing on pesticide bioremediation has investigated microbial-pesticide 
interactions against the organophosphate class of pesticides in vitro or in the 
environment, rather than directly in humans. Future studies should explore if other strains 
of lactobacilli have the potential to metabolize widely used classes of pesticide 
compounds in vivo. Most Lactobacillus species likely share common passive mechanisms 
for reducing host damage in response to various toxin exposures. However, it is also 
possible that certain strains have gene suites for active enzymatic degradation or 
sequestration of various pesticides (25).  
In conclusion, probiotic lactobacilli can confer a variety of beneficial affects to humans 
and animals in the form of nutritious and affordable foods and supplements. Their 
potential to prevent systemic absorption of pesticides merits further study, especially 
given the continued widespread use of pesticides and their known potential to cause 
morbidity and death. More generally, by establishing mechanistic interactions between 
bacteria and drug metabolism, the present findings could be important for future 
optimization of medication dosing. It is reasonable to suggest that in the near future many 
therapeutics and/or diagnostics will target the microbiome. 
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